GWAS1727580_H |
GCST012079 |
Fasting insulin |
105,056 European ancestry individuals |
C |
0.713199 |
7E-11 |
10.155 |
rs7903146 |
0.017926 |
blood insulin amount (OBA:VT0001560)
|
PMID:33402679 |
GWAS1699246_H |
GCST004066 |
Hip circumference |
up to 56,910 European ancestry men, up to 86,570 European ancestry women |
T |
0.2858 |
7E-8 |
7.155 |
rs7903146 |
0.0298 |
hip circumference (OBA:1000032)
|
PMID:25673412 |
GWAS1699365_H |
GCST001526 |
Fasting blood insulin (BMI interaction) |
Up to 51,750 European ancestry individuals |
T |
0.2871 |
0.000003 |
5.523 |
rs7903146 |
7.362E-4 |
body mass index (EFO:0004340) blood insulin amount (OBA:VT0001560)
|
PMID:22581228 |
GWAS1699378_H |
GCST001527 |
Fasting blood glucose (BMI interaction) |
Up to 58,074 European ancestry individuals |
T |
0.2886 |
2E-14 |
13.699 |
rs7903146 |
0.0024 |
obsolete_fasting blood glucose measurement (EFO:0004465) body mass index (EFO:0004340)
|
PMID:22581228 |
GWAS1699445_H |
GCST005186 |
Fasting blood glucose |
Up to 58,074 European ancestry individuals |
T |
0.2876 |
1E-9 |
9 |
rs7903146 |
0.0212 |
obsolete_fasting blood glucose measurement (EFO:0004465)
|
PMID:22581228 |
GWAS1699452_H |
GCST005185 |
Fasting blood insulin |
Up to 51,750 European ancestry individuals |
T |
0.2724 |
3E-7 |
6.523 |
rs7903146 |
0.0185 |
blood insulin amount (OBA:VT0001560)
|
PMID:22581228 |
None Available |
GCST004066 |
Hip circumference |
up to 56,910 European ancestry men, up to 86,570 European ancestry women |
T |
0.2858 |
0.000003 |
5.523 |
rs7903146 |
0.0239 |
hip circumference (OBA:1000032)
|
PMID:25673412 |
GWAS1699596_H |
GCST004066 |
Hip circumference |
up to 56,910 European ancestry men, up to 86,570 European ancestry women |
T |
0.2858 |
2E-11 |
10.699 |
rs7903146 |
0.0264 |
hip circumference (OBA:1000032)
|
PMID:25673412 |
GWAS539606_H |
GCST000712 |
Type 2 diabetes |
8,130 European ancestry cases, 38,987 European ancestry controls |
T |
NR |
2E-51 |
50.699 |
rs7903146 |
1.4 |
|
PMID:20581827 |
GWAS1115971_H |
GCST005951 |
Body mass index |
up to 309,889 European ancestry individuals |
T |
0.28797015591893 |
3E-13 |
12.523 |
rs7903146 |
0.021989034 |
body mass index (EFO:0004340)
|
PMID:26426971 |
GWAS1117618_H |
GCST004758 |
Type 2 diabetes |
2,499 Hispanic/Latino ancestry cases, 5,247 Hispanic/Latino ancestry controls |
T |
0.25 |
1E-11 |
11 |
rs7903146 |
1.36 |
|
PMID:28254843 |
GWAS1635325_H |
GCST90475685 |
Polyneuropathy in diabetes (PheCode 250.6) |
4,528 African American or Afro-Caribbean cases, 114,074 African American or Afro-Caribbean controls |
C |
0.7058 |
2E-22 |
21.699 |
rs7903146 |
0.226 |
|
PMID:39024449 |
GWAS1635335_H |
GCST90475686 |
Polyneuropathy in diabetes (PheCode 250.6) |
18,533 European ancestry cases, 421,371 European ancestry controls |
C |
0.7051 |
1E-76 |
76 |
rs7903146 |
0.2019 |
|
PMID:39024449 |
GWAS1635337_H |
GCST90479652 |
PT international normalized ratio (INR, minimum, inv-norm transformed) |
49,241 African American or Afro-Caribbean individuals, 23,426 Hispanic or Latin American individuals, 1,793 East Asian ancestry individuals, 165,202 European ancestry individuals |
C |
0.7101 |
9E-13 |
12.046 |
rs7903146 |
0.02501 |
prothrombin time measurement (EFO:0008390)
|
PMID:39024449 |
GWAS1635531_H |
GCST90479639 |
hemoglobin (mean, inv-norm transformed) |
114,985 African American or Afro-Caribbean individuals, 55,838 Hispanic or Latin American individuals, 5,963 East Asian ancestry individuals, 407,894 European ancestry individuals |
C |
0.7102 |
1E-33 |
33 |
rs7903146 |
0.03128 |
hemoglobin measurement (EFO:0004509)
|
PMID:39024449 |
GWAS1635615_H |
GCST90479630 |
hematocrit (minimum, inv-norm transformed) |
114,988 African American or Afro-Caribbean individuals, 55,841 Hispanic or Latin American individuals, 5,964 East Asian ancestry individuals, 407,854 European ancestry individuals |
C |
0.7102 |
1E-31 |
31 |
rs7903146 |
0.02994 |
hematocrit (EFO:0004348)
|
PMID:39024449 |
GWAS1635751_H |
GCST90479629 |
hematocrit (mean, inv-norm transformed) |
114,988 African American or Afro-Caribbean individuals, 55,841 Hispanic or Latin American individuals, 5,964 East Asian ancestry individuals, 407,852 European ancestry individuals |
C |
0.7102 |
2E-43 |
42.699 |
rs7903146 |
0.03734 |
hematocrit (EFO:0004348)
|
PMID:39024449 |
GWAS1635803_H |
GCST90475753 |
Hyperpotassemia (PheCode 276.13) |
17,226 European ancestry cases, 415,141 European ancestry controls |
C |
0.7047 |
2E-21 |
20.699 |
rs7903146 |
0.1095 |
Abnormality of metabolism/homeostasis (HP:0001939)
|
PMID:39024449 |
GWAS1635859_H |
GCST90475735 |
Gout (PheCode 274.1) |
42,034 European ancestry cases, 397,989 European ancestry controls |
C |
0.7041 |
2E-12 |
11.699 |
rs7903146 |
0.05243 |
gout (EFO:0004274)
|
PMID:39024449 |
None Available |
GCST90479638 |
hemoglobin (maximum, inv-norm transformed) |
114,984 African American or Afro-Caribbean individuals, 55,834 Hispanic or Latin American individuals, 5,963 East Asian ancestry individuals, 407,887 European ancestry individuals |
C |
0.7102 |
1E-33 |
33 |
rs7903146 |
0.03264 |
hemoglobin measurement (EFO:0004509)
|
PMID:39024449 |
GWAS1636587_H |
GCST90475660 |
Type 1 diabetes (PheCode 250.1) |
6,451 African American or Afro-Caribbean cases, 109,410 African American or Afro-Caribbean controls |
C |
0.7066 |
1E-39 |
39 |
rs7903146 |
0.2583 |
|
PMID:39024449 |
GWAS1636598_H |
GCST90475669 |
Type 2 diabetes with renal manifestations (PheCode 250.22) |
9,879 African American or Afro-Caribbean cases, 107,756 African American or Afro-Caribbean controls |
C |
0.7055 |
3E-39 |
38.523 |
rs7903146 |
0.2141 |
type 2 diabetes nephropathy (EFO:0004997)
|
PMID:39024449 |
GWAS1636634_H |
GCST90475661 |
Type 1 diabetes (PheCode 250.1) |
16,971 European ancestry cases, 418,767 European ancestry controls |
C |
0.7055 |
1E-65 |
65 |
rs7903146 |
0.196 |
|
PMID:39024449 |
GWAS1636644_H |
GCST90475659 |
Type 1 diabetes (PheCode 250.1) |
2,295 Hispanic or Latin American cases, 55,134 Hispanic or Latin American controls |
C |
0.7397 |
9E-12 |
11.046 |
rs7903146 |
0.2316 |
|
PMID:39024449 |
GWAS1636657_H |
GCST90475671 |
Type 2 diabetes with ophthalmic manifestations (PheCode 250.23) |
5,479 Hispanic or Latin American cases, 51,558 Hispanic or Latin American controls |
C |
0.7398 |
1E-28 |
28 |
rs7903146 |
0.2654 |
diabetic eye disease (EFO:0009486)
|
PMID:39024449 |
GWAS1636692_H |
GCST90475672 |
Type 2 diabetes with ophthalmic manifestations (PheCode 250.23) |
11,204 African American or Afro-Caribbean cases, 103,814 African American or Afro-Caribbean controls |
C |
0.7066 |
3E-67 |
66.523 |
rs7903146 |
0.2655 |
diabetic eye disease (EFO:0009486)
|
PMID:39024449 |
GWAS1637225_H |
GCST90475731 |
Gout and other crystal arthrop (PheCode 274) |
44,197 European ancestry cases, 393,782 European ancestry controls |
C |
0.7041 |
7E-13 |
12.155 |
rs7903146 |
0.05212 |
gout (EFO:0004274)
|
PMID:39024449 |
GWAS1637248_H |
GCST90479661 |
low density lipoprotein cholesterol (LDLC, mean, inv-norm transformed) |
113,213 African American or Afro-Caribbean individuals, 54,980 Hispanic or Latin American individuals, 6,010 East Asian ancestry individuals, 404,741 European ancestry individuals |
C |
0.71 |
5E-13 |
12.302 |
rs7903146 |
0.01939 |
low density lipoprotein cholesterol measurement (EFO:0004611)
|
PMID:39024449 |
GWAS1637339_H |
GCST90479662 |
low density lipoprotein cholesterol (LDLC, minimum, inv-norm transformed) |
113,217 African American or Afro-Caribbean individuals, 54,983 Hispanic or Latin American individuals, 6,010 East Asian ancestry individuals, 404,745 European ancestry individuals |
C |
0.71 |
3E-26 |
25.523 |
rs7903146 |
0.02795 |
low density lipoprotein cholesterol measurement (EFO:0004611)
|
PMID:39024449 |
GWAS1637486_H |
GCST90475687 |
Diabetic retinopathy (PheCode 250.7) |
5,658 Hispanic or Latin American cases, 51,648 Hispanic or Latin American controls |
C |
0.7395 |
3E-27 |
26.523 |
rs7903146 |
0.2533 |
diabetic retinopathy (EFO:0003770)
|
PMID:39024449 |
GWAS1637491_H |
GCST90475688 |
Diabetic retinopathy (PheCode 250.7) |
11,781 African American or Afro-Caribbean cases, 103,431 African American or Afro-Caribbean controls |
C |
0.7063 |
7E-72 |
71.155 |
rs7903146 |
0.2694 |
diabetic retinopathy (EFO:0003770)
|
PMID:39024449 |
GWAS1120513_H |
GCST005047 |
Type 2 diabetes |
6,377 European ancestry male cases, 5,794 European ancestry female cases, 22,243 European ancestry male controls, 34,619 European ancestry female controls |
T |
NR |
6E-92 |
91.222 |
rs7903146 |
1.39 |
|
PMID:22885922 |
GWAS1120590_H |
GCST005047 |
Type 2 diabetes |
6,377 European ancestry male cases, 5,794 European ancestry female cases, 22,243 European ancestry male controls, 34,619 European ancestry female controls |
T |
0.268379563153031 |
1E-139 |
139 |
rs7903146 |
1.39 |
|
PMID:22885922 |
GWAS1120725_H |
GCST005047 |
Type 2 diabetes |
6,377 European ancestry male cases, 5,794 European ancestry female cases, 22,243 European ancestry male controls, 34,619 European ancestry female controls |
T |
NR |
4E-73 |
72.398 |
rs7903146 |
1.39 |
|
PMID:22885922 |
GWAS1638321_H |
GCST90479541 |
chloride (minimum, inv-norm transformed) |
112,827 African American or Afro-Caribbean individuals, 54,550 Hispanic or Latin American individuals, 5,467 East Asian ancestry individuals, 412,365 European ancestry individuals |
C |
0.7099 |
5E-36 |
35.302 |
rs7903146 |
0.03356 |
chloride measurement (EFO:0009284)
|
PMID:39024449 |
GWAS1638421_H |
GCST90479540 |
chloride (mean, inv-norm transformed) |
112,886 African American or Afro-Caribbean individuals, 54,578 Hispanic or Latin American individuals, 5,468 East Asian ancestry individuals, 412,569 European ancestry individuals |
C |
0.71 |
2E-26 |
25.699 |
rs7903146 |
0.02935 |
chloride measurement (EFO:0009284)
|
PMID:39024449 |
GWAS1121435_H |
GCST006801 |
Type 2 diabetes |
4,040 British ancestry cases, 113,735 British ancestry controls |
T |
NR |
7E-45 |
44.155 |
rs7903146 |
1.4 |
|
PMID:26961502 |
GWAS1641842_H |
GCST90479588 |
Takes medication for Diabetes/sugar? |
13,958 African American or Afro-Caribbean cases, 41,547 African American or Afro-Caribbean controls, 7,497 Hispanic or Latin American cases, 21,817 Hispanic or Latin American controls, 852 East Asian ancestry cases, 2,695 East Asian ancestry controls, 67,092 European ancestry cases, 248,576 European ancestry controls |
C |
0.7098 |
1E-302 |
302 |
rs7903146 |
0.2521 |
diabetes mellitus (EFO:0000400) Drugs used in diabetes use measurement (EFO:0009924)
|
PMID:39024449 |
GWAS564819_H |
GCST007267 |
Systolic blood pressure |
365,998 European ancestry individuals, 63,490 African ancestry individuals, 22,802 Hispanic individuals, 4,792 Asian ancestry individuals, 2,695 Native American ancestry individuals |
T |
0.2906 |
4E-10 |
9.398 |
rs7903146 |
0.2209 |
systolic blood pressure (EFO:0006335)
|
PMID:30578418 |
GWAS1642913_H |
GCST90479581 |
diastolic blood pressure (DBP, mean, inv-normal transformed) |
119,332 African American or Afro-Caribbean individuals, 57,990 Hispanic or Latin American individuals, 6,421 East Asian ancestry individuals, 425,743 European ancestry individuals |
C |
0.7103 |
2E-18 |
17.699 |
rs7903146 |
0.02425 |
diastolic blood pressure change measurement (EFO:0006945)
|
PMID:39024449 |
GWAS1705082_H |
GCST008032 |
Fasting blood glucose |
6,457 African American individuals, 13,556 Hispanic/Latino individuals, 1,918 Asian ancestry individuals, 1,400 Native Hawaiian ancestry individuals, 412 Native American ancestry individuals, 168 individuals |
? |
NR |
8E-8 |
7.097 |
rs7903146 |
0.05717657 |
obsolete_fasting blood glucose measurement (EFO:0004465)
|
PMID:31217584 |
GWAS1643205_H |
GCST90479574 |
Biological Father: Diabetes / "Sugar" |
7,335 African American or Afro-Caribbean cases, 48,170 African American or Afro-Caribbean controls, 5,043 Hispanic or Latin American cases, 24,271 Hispanic or Latin American controls, 545 East Asian ancestry cases, 3,002 East Asian ancestry controls, 36,484 European ancestry cases, 279,184 European ancestry controls |
C |
0.7098 |
4E-68 |
67.398 |
rs7903146 |
0.1348 |
diabetes mellitus (EFO:0000400) family history (EFO:0000493)
|
PMID:39024449 |
GWAS1123081_H |
GCST007221 |
Type 2 diabetes |
822 Greek ancestry cases, 1,125 Greek ancestry controls |
T |
0.38 |
3E-11 |
10.523 |
rs7903146 |
1.66 |
|
PMID:30470734 |
GWAS1123083_H |
GCST007223 |
Schizophrenia vs type 2 diabetes |
924 Greek ancestry schizophrenia cases, 822 Greek ancestry T2D cases |
C |
0.61 |
1E-9 |
9 |
rs7903146 |
1.53 |
|
PMID:30470734 |
GWAS1124341_H |
GCST009004 |
Body mass index |
806,834 European ancestry individuals |
T |
0.2787 |
2E-23 |
22.699 |
rs7903146 |
0.0178 |
body mass index (EFO:0004340)
|
PMID:30239722 |
GWAS1644237_H |
GCST90475558 |
Screening for other diseases and disorders (PheCode 1010.3) |
156,707 European ancestry cases, 212,038 European ancestry controls |
C |
0.7042 |
4E-13 |
12.398 |
rs7903146 |
0.03597 |
infectious disease (EFO:0005741)
|
PMID:39024449 |
GWAS1126774_H |
GCST008994 |
Waist-to-hip ratio adjusted for BMI |
379,501 European ancestry female individuals |
T |
0.2798 |
1E-21 |
21 |
rs7903146 |
0.0181 |
BMI-adjusted waist-hip ratio (EFO:0007788)
|
PMID:30239722 |
GWAS1644730_H |
GCST90475676 |
Type 2 diabetes with neurological manifestations (PheCode 250.24) |
59,205 European ancestry cases, 375,439 European ancestry controls |
C |
0.705 |
8E-236 |
235.097 |
rs7903146 |
0.1993 |
diabetic neuropathy (EFO:1000783)
|
PMID:39024449 |
GWAS1644731_H |
GCST90475677 |
Diabetes type 2 with peripheral circulatory (PheCode 250.25) |
2,956 African American or Afro-Caribbean cases, 116,308 African American or Afro-Caribbean controls |
C |
0.7056 |
2E-17 |
16.699 |
rs7903146 |
0.2405 |
type 2 diabetes nephropathy (EFO:0004997)
|
PMID:39024449 |
None Available |
GCST90475657 |
Diabetes mellitus (PheCode 250) |
51,802 African American or Afro-Caribbean cases, 63,903 African American or Afro-Caribbean controls |
C |
0.7037 |
1E-139 |
139 |
rs7903146 |
0.2378 |
diabetes mellitus (EFO:0000400)
|
PMID:39024449 |
GWAS1644744_H |
GCST90475678 |
Diabetes type 2 with peripheral circulatory (PheCode 250.25) |
9,957 European ancestry cases, 432,767 European ancestry controls |
C |
0.7048 |
2E-35 |
34.699 |
rs7903146 |
0.187 |
type 2 diabetes nephropathy (EFO:0004997)
|
PMID:39024449 |
GWAS1644745_H |
GCST90475679 |
Insulin pump user (PheCode 250.3) |
4,132 African American or Afro-Caribbean cases, 114,507 African American or Afro-Caribbean controls |
C |
0.706 |
2E-19 |
18.699 |
rs7903146 |
0.2169 |
insulin measurement (EFO:0004467)
|
PMID:39024449 |
GWAS1644786_H |
GCST90475666 |
Type 2 diabetes (PheCode 250.2) |
51,551 African American or Afro-Caribbean cases, 64,463 African American or Afro-Caribbean controls |
C |
0.7038 |
1E-140 |
140 |
rs7903146 |
0.2386 |
|
PMID:39024449 |
GWAS1644859_H |
GCST90475665 |
Type 2 diabetes (PheCode 250.2) |
22,274 Hispanic or Latin American cases, 35,406 Hispanic or Latin American controls |
C |
0.7386 |
6E-47 |
46.222 |
rs7903146 |
0.2184 |
|
PMID:39024449 |
GWAS1644926_H |
GCST90475655 |
Secondary diabetes mellitus (PheCode 249) |
6,656 European ancestry cases, 435,640 European ancestry controls |
C |
0.7049 |
1E-27 |
27 |
rs7903146 |
0.2005 |
diabetes mellitus (EFO:0000400)
|
PMID:39024449 |
GWAS1644954_H |
GCST90475656 |
Diabetes mellitus (PheCode 250) |
22,361 Hispanic or Latin American cases, 35,203 Hispanic or Latin American controls |
C |
0.7384 |
2E-46 |
45.699 |
rs7903146 |
0.2162 |
diabetes mellitus (EFO:0000400)
|
PMID:39024449 |
GWAS1645094_H |
GCST90475674 |
Type 2 diabetes with neurological manifestations (PheCode 250.24) |
7,320 Hispanic or Latin American cases, 50,236 Hispanic or Latin American controls |
C |
0.7391 |
4E-16 |
15.398 |
rs7903146 |
0.1711 |
diabetic neuropathy (EFO:1000783)
|
PMID:39024449 |
GWAS1707859_H |
GCST004065 |
Waist circumference |
up to 56,910 European ancestry men, up to 86,570 European ancestry women |
T |
0.2866 |
4E-9 |
8.398 |
rs7903146 |
0.0219 |
waist circumference (OBA:1001085)
|
PMID:25673412 |
GWAS1707884_H |
GCST004065 |
Waist circumference |
up to 56,910 European ancestry men, up to 86,570 European ancestry women |
T |
0.2866 |
3E-8 |
7.523 |
rs7903146 |
0.0289 |
waist circumference (OBA:1001085)
|
PMID:25673412 |
GWAS1645246_H |
GCST90475675 |
Type 2 diabetes with neurological manifestations (PheCode 250.24) |
16,638 African American or Afro-Caribbean cases, 99,303 African American or Afro-Caribbean controls |
C |
0.7056 |
6E-68 |
67.222 |
rs7903146 |
0.2277 |
diabetic neuropathy (EFO:1000783)
|
PMID:39024449 |
GWAS1645270_H |
GCST90479623 |
Glucose (finger stick, maximum, inv-norm transformed) |
25,915 African American or Afro-Caribbean individuals, 69,705 European ancestry individuals, 10,805 Hispanic or Latin American individuals |
C |
0.6901 |
4E-65 |
64.398 |
rs7903146 |
0.08482 |
glucose measurement (EFO:0004468)
|
PMID:39024449 |
GWAS1645276_H |
GCST90479624 |
Glucose (finger stick, mean, inv-norm transformed) |
25,893 African American or Afro-Caribbean individuals, 69,680 European ancestry individuals, 10,798 Hispanic or Latin American individuals |
C |
0.6901 |
1E-74 |
74 |
rs7903146 |
0.09157 |
glucose measurement (EFO:0004468)
|
PMID:39024449 |
GWAS578480_H |
GCST007269 |
Pulse pressure |
365,998 European ancestry individuals, 63,490 African ancestry individuals, 22,802 Hispanic individuals, 4,792 Asian ancestry individuals, 2,695 Native American ancestry individuals |
T |
0.2904 |
9E-17 |
16.046 |
rs7903146 |
0.2209 |
pulse pressure measurement (EFO:0005763)
|
PMID:30578418 |
GWAS1645408_H |
GCST90479628 |
hematocrit (maximum, inv-norm transformed) |
114,986 African American or Afro-Caribbean individuals, 55,837 Hispanic or Latin American individuals, 5,964 East Asian ancestry individuals, 407,836 European ancestry individuals |
C |
0.7102 |
3E-41 |
40.523 |
rs7903146 |
0.03755 |
hematocrit (EFO:0004348)
|
PMID:39024449 |
GWAS1645544_H |
GCST90475791 |
Anemia in chronic kidney disease (PheCode 285.21) |
5,158 African American or Afro-Caribbean cases, 114,510 African American or Afro-Caribbean controls |
C |
0.7049 |
2E-11 |
10.699 |
rs7903146 |
0.1487 |
chronic kidney disease (EFO:0003884)
|
PMID:39024449 |
GWAS1645750_H |
GCST90479627 |
Glucose (fasting status unknown, minimum, inv-norm transformed) |
118,147 African American or Afro-Caribbean individuals, 57,134 Hispanic or Latin American individuals, 6,299 East Asian ancestry individuals, 419,287 European ancestry individuals |
C |
0.7104 |
9E-101 |
100.046 |
rs7903146 |
0.05042 |
glucose measurement (EFO:0004468)
|
PMID:39024449 |
GWAS1646194_H |
GCST90479877 |
Type 1 diabetes with ophthalmic manifestations (PheCode 250.13) |
738 African American or Afro-Caribbean cases, 119,755 African American or Afro-Caribbean controls, 2,517 European ancestry cases, 445,450 European ancestry controls, 314 Hispanic or Latin American cases, 59,045 Hispanic or Latin American controls |
C |
0.7081 |
5E-20 |
19.302 |
rs7903146 |
0.2369 |
|
PMID:39024449 |
None Available |
GCST90479878 |
Type 1 diabetes with neurological manifestations (PheCode 250.14) |
847 African American or Afro-Caribbean cases, 119,910 African American or Afro-Caribbean controls, 3,812 European ancestry cases, 443,756 European ancestry controls, 309 Hispanic or Latin American cases, 59,098 Hispanic or Latin American controls |
C |
0.7079 |
2E-12 |
11.699 |
rs7903146 |
0.1557 |
|
PMID:39024449 |
GWAS1646242_H |
GCST90479879 |
Type 1 diabetes (PheCode 250.1) |
6,451 African American or Afro-Caribbean cases, 109,410 African American or Afro-Caribbean controls, 16,971 European ancestry cases, 418,767 European ancestry controls, 2,295 Hispanic or Latin American cases, 55,134 Hispanic or Latin American controls |
C |
0.7089 |
4E-98 |
97.398 |
rs7903146 |
0.2159 |
|
PMID:39024449 |
GWAS1646379_H |
GCST90479874 |
Secondary diabetes mellitus (PheCode 249) |
2,358 African American or Afro-Caribbean cases, 115,937 African American or Afro-Caribbean controls, 6,656 European ancestry cases, 435,640 European ancestry controls, 1,018 Hispanic or Latin American cases, 57,347 Hispanic or Latin American controls |
C |
0.7083 |
2E-34 |
33.699 |
rs7903146 |
0.1928 |
diabetes mellitus (EFO:0000400)
|
PMID:39024449 |
GWAS1646405_H |
GCST90479882 |
Type 2 diabetes with ophthalmic manifestations (PheCode 250.23) |
11,204 African American or Afro-Caribbean cases, 103,814 African American or Afro-Caribbean controls, 5,479 Hispanic or Latin American cases, 51,558 Hispanic or Latin American controls, 459 East Asian ancestry cases, 6,108 East Asian ancestry controls, 28,561 European ancestry cases, 402,796 European ancestry controls |
C |
0.712 |
6E-259 |
258.222 |
rs7903146 |
0.2815 |
diabetic eye disease (EFO:0009486)
|
PMID:39024449 |
GWAS1646476_H |
GCST90479881 |
Type 2 diabetes with renal manifestations (PheCode 250.22) |
9,879 African American or Afro-Caribbean cases, 107,756 African American or Afro-Caribbean controls, 3,709 Hispanic or Latin American cases, 54,509 Hispanic or Latin American controls, 431 East Asian ancestry cases, 6,276 East Asian ancestry controls, 25,234 European ancestry cases, 413,872 European ancestry controls |
C |
0.7114 |
8E-128 |
127.097 |
rs7903146 |
0.2085 |
type 2 diabetes nephropathy (EFO:0004997)
|
PMID:39024449 |
GWAS1646490_H |
GCST90476254 |
Osteoarthritis, localized (PheCode 740.1) |
108,659 European ancestry cases, 293,849 European ancestry controls |
C |
0.7044 |
8E-13 |
12.097 |
rs7903146 |
0.0376 |
|
PMID:39024449 |
GWAS1646738_H |
GCST90479883 |
Type 2 diabetes with neurological manifestations (PheCode 250.24) |
16,638 African American or Afro-Caribbean cases, 99,303 African American or Afro-Caribbean controls, 7,320 Hispanic or Latin American cases, 50,236 Hispanic or Latin American controls, 443 East Asian ancestry cases, 6,209 East Asian ancestry controls, 59,205 European ancestry cases, 375,439 European ancestry controls |
C |
0.7112 |
7E-203 |
202.155 |
rs7903146 |
0.2036 |
diabetic neuropathy (EFO:1000783)
|
PMID:39024449 |
GWAS1646879_H |
GCST90479884 |
Diabetes type 2 with peripheral circulatory (PheCode 250.25) |
2,956 African American or Afro-Caribbean cases, 116,308 African American or Afro-Caribbean controls, 9,957 European ancestry cases, 432,767 European ancestry controls, 1,343 Hispanic or Latin American cases, 57,386 Hispanic or Latin American controls |
C |
0.7082 |
2E-48 |
47.699 |
rs7903146 |
0.1953 |
type 2 diabetes nephropathy (EFO:0004997)
|
PMID:39024449 |
GWAS1647013_H |
GCST90479886 |
Insulin pump user (PheCode 250.3) |
4,132 African American or Afro-Caribbean cases, 114,507 African American or Afro-Caribbean controls, 11,279 European ancestry cases, 430,909 European ancestry controls, 1,835 Hispanic or Latin American cases, 56,635 Hispanic or Latin American controls |
C |
0.7085 |
8E-65 |
64.097 |
rs7903146 |
0.2088 |
insulin measurement (EFO:0004467)
|
PMID:39024449 |
GWAS1132013_H |
GCST009379 |
Type 2 diabetes |
74,124 European ancestry cases, 824,006 European ancestry controls |
T |
0.295 |
6E-447 |
446.222 |
rs7903146 |
1.37 |
|
PMID:30297969 |
GWAS1647056_H |
GCST90479888 |
Other abnormal glucose (PheCode 250.42) |
11,690 African American or Afro-Caribbean cases, 97,792 African American or Afro-Caribbean controls, 4,552 Hispanic or Latin American cases, 50,280 Hispanic or Latin American controls, 374 East Asian ancestry cases, 5,990 East Asian ancestry controls, 31,907 European ancestry cases, 383,507 European ancestry controls |
C |
0.7116 |
8E-12 |
11.097 |
rs7903146 |
0.0518 |
Abnormal glucose homeostasis (HP:0011014)
|
PMID:39024449 |
GWAS1647115_H |
GCST90479890 |
Polyneuropathy in diabetes (PheCode 250.6) |
4,528 African American or Afro-Caribbean cases, 114,074 African American or Afro-Caribbean controls, 18,533 European ancestry cases, 421,371 European ancestry controls, 2,180 Hispanic or Latin American cases, 56,290 Hispanic or Latin American controls |
C |
0.7084 |
2E-84 |
83.699 |
rs7903146 |
0.2035 |
|
PMID:39024449 |
GWAS1647385_H |
GCST90479891 |
Diabetic retinopathy (PheCode 250.7) |
11,781 African American or Afro-Caribbean cases, 103,431 African American or Afro-Caribbean controls, 5,658 Hispanic or Latin American cases, 51,648 Hispanic or Latin American controls, 483 East Asian ancestry cases, 6,078 East Asian ancestry controls, 29,668 European ancestry cases, 402,541 European ancestry controls |
C |
0.7118 |
3E-271 |
270.523 |
rs7903146 |
0.2823 |
diabetic retinopathy (EFO:0003770)
|
PMID:39024449 |
GWAS1647389_H |
GCST90479971 |
Anemia in chronic kidney disease (PheCode 285.21) |
5,158 African American or Afro-Caribbean cases, 114,510 African American or Afro-Caribbean controls, 8,844 European ancestry cases, 436,730 European ancestry controls, 1,419 Hispanic or Latin American cases, 57,865 Hispanic or Latin American controls |
C |
0.7077 |
5E-16 |
15.302 |
rs7903146 |
0.1054 |
chronic kidney disease (EFO:0003884)
|
PMID:39024449 |
GWAS1647439_H |
GCST90479733 |
Biological Grandparent (paternal): Diabetes / "Sugar" |
3,515 African American or Afro-Caribbean cases, 51,990 African American or Afro-Caribbean controls, 19,882 European ancestry cases, 295,786 European ancestry controls, 2,261 Hispanic or Latin American cases, 27,053 Hispanic or Latin American controls |
C |
0.7075 |
7E-14 |
13.155 |
rs7903146 |
0.07719 |
diabetes mellitus (EFO:0000400) family history (EFO:0000493)
|
PMID:39024449 |
None Available |
GCST009001 |
Body mass index |
374,756 European ancestry male individuals |
T |
0.2787 |
2E-23 |
22.699 |
rs7903146 |
0.0178 |
body mass index (EFO:0004340)
|
PMID:30239722 |
GWAS1647597_H |
GCST90479764 |
Acquired absence of limb (PheCode 1089) |
1,667 African American or Afro-Caribbean cases, 119,771 African American or Afro-Caribbean controls, 5,355 European ancestry cases, 444,321 European ancestry controls, 646 Hispanic or Latin American cases, 59,095 Hispanic or Latin American controls |
C |
0.7077 |
2E-13 |
12.699 |
rs7903146 |
0.1328 |
amputation (EFO:0009632)
|
PMID:39024449 |
GWAS1647602_H |
GCST90479765 |
Dermatophytosis of nail (PheCode 110.11) |
28,312 African American or Afro-Caribbean cases, 82,778 African American or Afro-Caribbean controls, 10,074 Hispanic or Latin American cases, 44,970 Hispanic or Latin American controls, 450 East Asian ancestry cases, 6,087 East Asian ancestry controls, 74,612 European ancestry cases, 343,052 European ancestry controls |
C |
0.7107 |
1E-14 |
14 |
rs7903146 |
0.04393 |
|
PMID:39024449 |
GWAS1647647_H |
GCST90479759 |
Screening for other diseases and disorders (PheCode 1010.3) |
43,803 African American or Afro-Caribbean cases, 54,128 African American or Afro-Caribbean controls, 22,095 Hispanic or Latin American cases, 25,942 Hispanic or Latin American controls, 2,222 East Asian ancestry cases, 3,229 East Asian ancestry controls, 156,707 European ancestry cases, 212,038 European ancestry controls |
C |
0.7103 |
1E-17 |
17 |
rs7903146 |
0.04008 |
infectious disease (EFO:0005741)
|
PMID:39024449 |
None Available |
GCST009764 |
Body mass index |
35,606 African American individuals, 26,048 Hispanic/Latino individuals, 22,466 Asian or Native Hawaiian ancestry individuals, 17,859 European ancestry individuals, 535 Native American individuals |
A |
NR |
3E-13 |
12.523 |
rs7903146 |
0.0075 |
body mass index (EFO:0004340)
|
PMID:29381148 |
None Available |
GCST90479767 |
Dermatophytosis (PheCode 110.1) |
36,994 African American or Afro-Caribbean cases, 69,578 African American or Afro-Caribbean controls, 13,747 Hispanic or Latin American cases, 39,052 Hispanic or Latin American controls, 772 East Asian ancestry cases, 5,454 East Asian ancestry controls, 95,136 European ancestry cases, 306,081 European ancestry controls |
C |
0.7106 |
3E-11 |
10.523 |
rs7903146 |
0.03484 |
|
PMID:39024449 |
GWAS597837_H |
GCST002783 |
Body mass index |
up to 104,666 European ancestry male individuals, up to 132,115 European ancestry female individuals, 370 African American male individuals, 517 African American female individuals, 512 Hispanic male individuals, 764 Hispanic female individuals |
C |
0.713 |
1E-11 |
11 |
rs7903146 |
0.023 |
body mass index (EFO:0004340)
|
PMID:25673413 |
GWAS1144242_H |
GCST009858 |
Waist-to-hip ratio adjusted for BMI |
457,690 European ancestry individuals |
? |
NR |
2E-21 |
20.699 |
rs7903146 |
N/A |
BMI-adjusted waist-hip ratio (EFO:0007788)
|
PMID:31669095 |
GWAS1649984_H |
GCST90480055 |
Retinal edema (PheCode 362.9) |
1,947 African American or Afro-Caribbean cases, 118,144 African American or Afro-Caribbean controls, 5,397 European ancestry cases, 440,745 European ancestry controls, 715 Hispanic or Latin American cases, 58,495 Hispanic or Latin American controls |
C |
0.7078 |
3E-22 |
21.523 |
rs7903146 |
0.1691 |
|
PMID:39024449 |
None Available |
GCST90476310 |
potassium (minimum, inv-norm transformed) |
421,506 European ancestry individuals |
C |
0.7041 |
1E-11 |
11 |
rs7903146 |
0.01821 |
potassium measurement (EFO:0009283)
|
PMID:39024449 |
GWAS1650551_H |
GCST90476307 |
potassium (mean, inv-norm transformed) |
421,503 European ancestry individuals |
C |
0.7041 |
6E-50 |
49.222 |
rs7903146 |
0.03942 |
potassium measurement (EFO:0009283)
|
PMID:39024449 |
GWAS1650696_H |
GCST90475330 |
Glucose (fasting status unknown, mean, inv-norm transformed) |
57,284 Hispanic or Latin American individuals |
C |
0.7389 |
4E-40 |
39.398 |
rs7903146 |
0.08863 |
glucose measurement (EFO:0004468)
|
PMID:39024449 |
GWAS1650708_H |
GCST90476304 |
potassium (maximum, inv-norm transformed) |
421,297 European ancestry individuals |
C |
0.7041 |
6E-53 |
52.222 |
rs7903146 |
0.03934 |
potassium measurement (EFO:0009283)
|
PMID:39024449 |
None Available |
GCST90476303 |
potassium (maximum, inv-norm transformed) |
118,330 African American or Afro-Caribbean individuals |
C |
0.7045 |
2E-17 |
16.699 |
rs7903146 |
0.04072 |
potassium measurement (EFO:0009283)
|
PMID:39024449 |
GWAS1650776_H |
GCST90476306 |
potassium (mean, inv-norm transformed) |
118,506 African American or Afro-Caribbean individuals |
C |
0.7046 |
7E-15 |
14.155 |
rs7903146 |
0.0369 |
potassium measurement (EFO:0009283)
|
PMID:39024449 |
GWAS1650808_H |
GCST90475331 |
Glucose (fasting status unknown, mean, inv-norm transformed) |
118,233 African American or Afro-Caribbean individuals |
C |
0.7047 |
3E-120 |
119.523 |
rs7903146 |
0.1137 |
glucose measurement (EFO:0004468)
|
PMID:39024449 |
GWAS1651058_H |
GCST90475335 |
Glucose (fasting status unknown, minimum, inv-norm transformed) |
419,287 European ancestry individuals |
C |
0.7042 |
3E-128 |
127.523 |
rs7903146 |
0.06238 |
glucose measurement (EFO:0004468)
|
PMID:39024449 |
None Available |
GCST90475155 |
Body mass index (BMI, mean, inv-normal transformed) |
118,993 African American or Afro-Caribbean individuals |
C |
0.7047 |
2E-18 |
17.699 |
rs7903146 |
0.0437 |
body mass index (EFO:0004340)
|
PMID:39024449 |
None Available |
GCST90475158 |
Body mass index (BMI, minimum, inv-normal transformed) |
118,992 African American or Afro-Caribbean individuals |
C |
0.7047 |
4E-16 |
15.398 |
rs7903146 |
0.04078 |
body mass index (EFO:0004340)
|
PMID:39024449 |
GWAS1651338_H |
GCST90475328 |
Glucose (fasting status unknown, maximum, inv-norm transformed) |
117,850 African American or Afro-Caribbean individuals |
C |
0.7047 |
1E-110 |
110 |
rs7903146 |
0.1078 |
glucose measurement (EFO:0004468)
|
PMID:39024449 |
GWAS1651633_H |
GCST90475325 |
Glucose (finger stick, mean, inv-norm transformed) |
25,893 African American or Afro-Caribbean individuals |
C |
0.685 |
3E-18 |
17.523 |
rs7903146 |
0.08896 |
glucose measurement (EFO:0004468)
|
PMID:39024449 |
GWAS1651634_H |
GCST90475324 |
Glucose (finger stick, maximum, inv-norm transformed) |
69,705 European ancestry individuals |
C |
0.6858 |
4E-46 |
45.398 |
rs7903146 |
0.08214 |
glucose measurement (EFO:0004468)
|
PMID:39024449 |
GWAS1651649_H |
GCST90475326 |
Glucose (finger stick, mean, inv-norm transformed) |
69,680 European ancestry individuals |
C |
0.6858 |
4E-58 |
57.398 |
rs7903146 |
0.09281 |
glucose measurement (EFO:0004468)
|
PMID:39024449 |
GWAS1153945_H |
GCST007077 |
Type 2 diabetes |
approximately 459,000 European ancestry individuals |
? |
NR |
3E-203 |
202.523 |
rs7903146 |
N/A |
|
PMID:30595370 |
None Available |
GCST90475323 |
Glucose (finger stick, maximum, inv-norm transformed) |
25,915 African American or Afro-Caribbean individuals |
C |
0.685 |
1E-17 |
17 |
rs7903146 |
0.08709 |
glucose measurement (EFO:0004468)
|
PMID:39024449 |
None Available |
GCST90475327 |
Glucose (fasting status unknown, maximum, inv-norm transformed) |
57,272 Hispanic or Latin American individuals |
C |
0.7388 |
2E-34 |
33.699 |
rs7903146 |
0.0823 |
glucose measurement (EFO:0004468)
|
PMID:39024449 |
None Available |
GCST90475340 |
hematocrit (mean, inv-norm transformed) |
114,988 African American or Afro-Caribbean individuals |
C |
0.7047 |
3E-11 |
10.523 |
rs7903146 |
0.02885 |
hematocrit (EFO:0004348)
|
PMID:39024449 |
GWAS1652448_H |
GCST90475205 |
High cholesterol |
176,604 European ancestry cases, 139,064 European ancestry controls |
C |
0.7054 |
6E-19 |
18.222 |
rs7903146 |
0.04552 |
Hypercholesterolemia (HP:0003124)
|
PMID:39024449 |
None Available |
GCST90475252 |
diastolic blood pressure (DBP, maximum, inv-normal transformed) |
425,680 European ancestry individuals |
C |
0.704 |
2E-11 |
10.699 |
rs7903146 |
0.01812 |
diastolic blood pressure (EFO:0006336)
|
PMID:39024449 |
GWAS1158526_H |
GCST004557 |
Body mass index |
2,518 African American women, 86,278 European ancestry women, 1,773 Filipino ancestry women, 1,030 Indian ancestry women, 1,457 African American men, 55,137 European ancestry men, 7,648 Indian ancestry men, 5,527 European ancestry individuals |
C |
0.7145 |
5E-8 |
7.302 |
rs7903146 |
0.0315 |
physical activity measurement (EFO:0008002) body mass index (EFO:0004340)
|
PMID:28448500 |
GWAS1652995_H |
GCST90475263 |
Diabetes / "Sugar" |
8,910 Hispanic or Latin American cases, 20,404 Hispanic or Latin American controls |
C |
0.7346 |
3E-19 |
18.523 |
rs7903146 |
0.1911 |
diabetes mellitus (EFO:0000400)
|
PMID:39024449 |
GWAS1652999_H |
GCST90475264 |
Diabetes / "Sugar" |
16,718 African American or Afro-Caribbean cases, 38,787 African American or Afro-Caribbean controls |
C |
0.7053 |
7E-68 |
67.155 |
rs7903146 |
0.2546 |
diabetes mellitus (EFO:0000400)
|
PMID:39024449 |
GWAS1653163_H |
GCST90475244 |
Biological Father: Diabetes / "Sugar" |
7,335 African American or Afro-Caribbean cases, 48,170 African American or Afro-Caribbean controls |
C |
0.7053 |
4E-11 |
10.398 |
rs7903146 |
0.1277 |
diabetes mellitus (EFO:0000400) family history (EFO:0000493)
|
PMID:39024449 |
GWAS1653325_H |
GCST90475266 |
Takes medication for Diabetes/sugar? |
7,497 Hispanic or Latin American cases, 21,817 Hispanic or Latin American controls |
C |
0.7346 |
3E-17 |
16.523 |
rs7903146 |
0.1873 |
diabetes mellitus (EFO:0000400) Drugs used in diabetes use measurement (EFO:0009924)
|
PMID:39024449 |
GWAS1653328_H |
GCST90475267 |
Takes medication for Diabetes/sugar? |
13,958 African American or Afro-Caribbean cases, 41,547 African American or Afro-Caribbean controls |
C |
0.7053 |
2E-64 |
63.699 |
rs7903146 |
0.2602 |
diabetes mellitus (EFO:0000400) Drugs used in diabetes use measurement (EFO:0009924)
|
PMID:39024449 |
GWAS1160361_H |
GCST004558 |
Body mass index (joint analysis main effects and physical activity interaction) |
2,518 African American women, 86,278 European ancestry women, 1,773 Filipino ancestry women, 1,030 Indian ancestry women, 1,457 African American men, 55,137 European ancestry men, 7,648 Indian ancestry men, 5,527 European ancestry individuals |
? |
NR |
2E-9 |
8.699 |
rs7903146 |
N/A |
physical activity measurement (EFO:0008002) body mass index (EFO:0004340)
|
PMID:28448500 |
GWAS1160426_H |
GCST004558 |
Body mass index (joint analysis main effects and physical activity interaction) |
2,518 African American women, 86,278 European ancestry women, 1,773 Filipino ancestry women, 1,030 Indian ancestry women, 1,457 African American men, 55,137 European ancestry men, 7,648 Indian ancestry men, 5,527 European ancestry individuals |
? |
NR |
2E-7 |
6.699 |
rs7903146 |
N/A |
physical activity measurement (EFO:0008002) body mass index (EFO:0004340)
|
PMID:28448500 |
GWAS636676_H |
GCST003540 |
Clinical laboratory measurements |
17,347 European ancestry individuals |
? |
NR |
6E-24 |
23.222 |
rs7903146 |
N/A |
clinical laboratory measurement (EFO:0004297) glucose measurement (EFO:0004468)
|
PMID:27897004 |
GWAS1160491_H |
GCST004499 |
BMI in non-smokers |
77,279 European ancestry women, 47,280 European ancestry men, 4,856 European ancestry individuals, 8,799 African American/Afro-Caribbean ancestry women, 1,803 African American/Afro-Caribbean ancestry men, 1,020 Indian Asian ancestry women, 6,691 Indian Asian ancestry men, 1,526 Filipino ancestry women, 2,469 Hispanic/Latino ancestry women, 1,318 Hispanic/Latino ancestry men |
T |
0.2894 |
7E-9 |
8.155 |
rs7903146 |
0.0341 |
body mass index (EFO:0004340)
|
PMID:28443625 |
GWAS1160492_H |
GCST004499 |
BMI in non-smokers |
77,279 European ancestry women, 47,280 European ancestry men, 4,856 European ancestry individuals, 8,799 African American/Afro-Caribbean ancestry women, 1,803 African American/Afro-Caribbean ancestry men, 1,020 Indian Asian ancestry women, 6,691 Indian Asian ancestry men, 1,526 Filipino ancestry women, 2,469 Hispanic/Latino ancestry women, 1,318 Hispanic/Latino ancestry men |
T |
0.2894 |
7E-10 |
9.155 |
rs7903146 |
0.0264 |
body mass index (EFO:0004340)
|
PMID:28443625 |
GWAS1680379_H |
GCST004559 |
Body mass index in physically active individuals |
1,957 African American women, 1,773 Filipino ancestry women, 305 Indian ancestry women, 67,609 European ancestry women, 1,206 African American men, 2,029 Indian ancestry men, 43,399 European ancestry men, at least 4,819 European ancestry individuals |
C |
0.7145 |
0.000001 |
6 |
rs7903146 |
0.0214 |
body mass index (EFO:0004340)
|
PMID:28448500 |
GWAS1161860_H |
GCST004557 |
Body mass index |
2,518 African American women, 86,278 European ancestry women, 1,773 Filipino ancestry women, 1,030 Indian ancestry women, 1,457 African American men, 55,137 European ancestry men, 7,648 Indian ancestry men, 5,527 European ancestry individuals |
C |
0.7145 |
5E-10 |
9.302 |
rs7903146 |
0.0243 |
physical activity measurement (EFO:0008002) body mass index (EFO:0004340)
|
PMID:28448500 |
GWAS1654742_H |
GCST90479509 |
Aspartate aminotransferase (AST, maximum, inv-norm transformed) |
112,550 African American or Afro-Caribbean individuals, 54,332 Hispanic or Latin American individuals, 5,839 East Asian ancestry individuals, 389,396 European ancestry individuals |
C |
0.7098 |
6E-13 |
12.222 |
rs7903146 |
0.01905 |
aspartate aminotransferase to alanine aminotransferase ratio (EFO:0010934)
|
PMID:39024449 |
GWAS1655185_H |
GCST90479510 |
Aspartate aminotransferase (AST, mean, inv-norm transformed) |
112,429 African American or Afro-Caribbean individuals, 54,250 Hispanic or Latin American individuals, 5,835 East Asian ancestry individuals, 389,192 European ancestry individuals |
C |
0.7098 |
4E-25 |
24.398 |
rs7903146 |
0.02886 |
aspartate aminotransferase to alanine aminotransferase ratio (EFO:0010934)
|
PMID:39024449 |
GWAS1166051_H |
GCST004497 |
Body mass index (joint analysis main effects and smoking interaction) |
98,173 European ancestry women, 64,373 European ancestry men, 5,829 European ancestry individuals, 10,500 African American/Afro-Caribbean ancestry women, 2,706 African American/Afro-Caribbean ancestry men, 1,030 Indian Asian ancestry women, 7,648 Indian Asian ancestry men, 1,793 Filipino ancestry women, 2,944 Hispanic/Latino ancestry women, 1,764 Hispanic/Latino ancestry men |
T |
0.2894 |
6E-9 |
8.222 |
rs7903146 |
N/A |
smoking behavior (EFO:0004318) body mass index (EFO:0004340)
|
PMID:28443625 |
GWAS1166052_H |
GCST004497 |
Body mass index (joint analysis main effects and smoking interaction) |
98,173 European ancestry women, 64,373 European ancestry men, 5,829 European ancestry individuals, 10,500 African American/Afro-Caribbean ancestry women, 2,706 African American/Afro-Caribbean ancestry men, 1,030 Indian Asian ancestry women, 7,648 Indian Asian ancestry men, 1,793 Filipino ancestry women, 2,944 Hispanic/Latino ancestry women, 1,764 Hispanic/Latino ancestry men |
T |
0.2894 |
4E-8 |
7.398 |
rs7903146 |
N/A |
smoking behavior (EFO:0004318) body mass index (EFO:0004340)
|
PMID:28443625 |
GWAS1166191_H |
GCST004487 |
Peak insulin response |
2,337 Hispanic individuals, 2,159 European ancestry individuals, 332 Pima Indian ancestry individuals |
T |
NR |
0.000007 |
5.155 |
rs7903146 |
0.105 |
peak insulin response measurement (EFO:0008000)
|
PMID:28490609 |
GWAS1166245_H |
GCST004495 |
BMI (adjusted for smoking behaviour) |
98,173 European ancestry women, 64,373 European ancestry men, 5,829 European ancestry individuals, 10,500 African American/Afro-Caribbean ancestry women, 2,706 African American/Afro-Caribbean ancestry men, 1,030 Indian Asian ancestry women, 7,648 Indian Asian ancestry men, 1,793 Filipino ancestry women, 2,944 Hispanic/Latino ancestry women, 1,764 Hispanic/Latino ancestry men |
T |
0.2894 |
1E-7 |
7 |
rs7903146 |
0.0273 |
smoking behavior (EFO:0004318) body mass index (EFO:0004340)
|
PMID:28443625 |
None Available |
GCST004495 |
BMI (adjusted for smoking behaviour) |
98,173 European ancestry women, 64,373 European ancestry men, 5,829 European ancestry individuals, 10,500 African American/Afro-Caribbean ancestry women, 2,706 African American/Afro-Caribbean ancestry men, 1,030 Indian Asian ancestry women, 7,648 Indian Asian ancestry men, 1,793 Filipino ancestry women, 2,944 Hispanic/Latino ancestry women, 1,764 Hispanic/Latino ancestry men |
T |
0.2894 |
1E-7 |
7 |
rs7903146 |
0.0195 |
smoking behavior (EFO:0004318) body mass index (EFO:0004340)
|
PMID:28443625 |
GWAS1170287_H |
GCST004894 |
Type 2 diabetes |
6,353 South Asian ancestry cases, 7,179 South Asian ancestry controls, 3,871 European ancestry cases, 16,427 European ancestry controls, 34,840 cases, 114,981 controls |
T |
0.3171 |
2E-184 |
183.699 |
rs7903146 |
0.3286 |
|
PMID:28869590 |
GWAS1170290_H |
GCST004894 |
Type 2 diabetes |
6,353 South Asian ancestry cases, 7,179 South Asian ancestry controls, 3,871 European ancestry cases, 16,427 European ancestry controls, 34,840 cases, 114,981 controls |
T |
0.2986 |
3E-23 |
22.523 |
rs7903146 |
0.1981 |
|
PMID:28869590 |
GWAS1656213_H |
GCST90479511 |
Aspartate aminotransferase (AST, minimum, inv-norm transformed) |
112,345 African American or Afro-Caribbean individuals, 54,221 Hispanic or Latin American individuals, 5,834 East Asian ancestry individuals, 389,315 European ancestry individuals |
C |
0.7098 |
6E-31 |
30.222 |
rs7903146 |
0.03212 |
aspartate aminotransferase to alanine aminotransferase ratio (EFO:0010934)
|
PMID:39024449 |
GWAS1170771_H |
GCST004894 |
Type 2 diabetes |
6,353 South Asian ancestry cases, 7,179 South Asian ancestry controls, 3,871 European ancestry cases, 16,427 European ancestry controls, 34,840 cases, 114,981 controls |
T |
0.3171 |
1E-219 |
219 |
rs7903146 |
0.301 |
|
PMID:28869590 |
GWAS1171547_H |
GCST004904 |
Body mass index |
up to 72,390 Japanese ancestry women, up to 85,894 Japanese ancestry men |
T |
0.044 |
9E-12 |
11.046 |
rs7903146 |
0.056 |
body mass index (EFO:0004340)
|
PMID:28892062 |
GWAS1171549_H |
GCST004904 |
Body mass index |
up to 72,390 Japanese ancestry women, up to 85,894 Japanese ancestry men |
T |
0.31 |
1E-18 |
18 |
rs7903146 |
0.028 |
body mass index (EFO:0004340)
|
PMID:28892062 |
GWAS1657874_H |
GCST90479525 |
Blood urea nitrogen (BUN, mean, inv-norm transformed) |
117,876 African American or Afro-Caribbean individuals, 57,109 Hispanic or Latin American individuals, 6,288 East Asian ancestry individuals, 418,647 European ancestry individuals |
C |
0.7104 |
1E-19 |
19 |
rs7903146 |
0.02362 |
blood urea nitrogen measurement (EFO:0004741)
|
PMID:39024449 |
GWAS1658115_H |
GCST90479521 |
Body mass index (BMI, maximum, inv-normal transformed) |
118,995 African American or Afro-Caribbean individuals, 57,796 Hispanic or Latin American individuals, 6,384 East Asian ancestry individuals, 424,231 European ancestry individuals |
C |
0.7102 |
2E-60 |
59.699 |
rs7903146 |
0.05615 |
body mass index (EFO:0004340)
|
PMID:39024449 |
GWAS1658136_H |
GCST90479522 |
Body mass index (BMI, mean, inv-normal transformed) |
118,993 African American or Afro-Caribbean individuals, 57,793 Hispanic or Latin American individuals, 6,384 East Asian ancestry individuals, 424,221 European ancestry individuals |
C |
0.7102 |
3E-60 |
59.523 |
rs7903146 |
0.05567 |
body mass index (EFO:0004340)
|
PMID:39024449 |
GWAS1658163_H |
GCST90479524 |
Blood urea nitrogen (BUN, maximum, inv-norm transformed) |
117,530 African American or Afro-Caribbean individuals, 57,007 Hispanic or Latin American individuals, 6,277 East Asian ancestry individuals, 418,135 European ancestry individuals |
C |
0.7104 |
3E-24 |
23.523 |
rs7903146 |
0.02521 |
blood urea nitrogen measurement (EFO:0004741)
|
PMID:39024449 |
GWAS1071192_H |
GCST000798 |
Glycated hemoglobin levels |
1,782 European ancestry individuals |
C |
0.72 |
1E-7 |
7 |
rs7903146 |
0.05 |
HbA1c measurement (EFO:0004541)
|
PMID:20849430 |
GWAS1658341_H |
GCST90479523 |
Body mass index (BMI, minimum, inv-normal transformed) |
118,992 African American or Afro-Caribbean individuals, 57,794 Hispanic or Latin American individuals, 6,384 East Asian ancestry individuals, 424,217 European ancestry individuals |
C |
0.7102 |
1E-53 |
53 |
rs7903146 |
0.04945 |
body mass index (EFO:0004340)
|
PMID:39024449 |
GWAS1181109_H |
GCST010556 |
Type 2 diabetes |
24,646 African American cases, 31,446 African American controls |
C |
0.706 |
6E-60 |
59.222 |
rs7903146 |
0.226 |
|
PMID:32541925 |
None Available |
GCST90479547 |
High cholesterol |
28,037 African American or Afro-Caribbean cases, 27,468 African American or Afro-Caribbean controls, 14,887 Hispanic or Latin American cases, 14,427 Hispanic or Latin American controls, 1,998 East Asian ancestry cases, 1,549 East Asian ancestry controls, 176,604 European ancestry cases, 139,064 European ancestry controls |
C |
0.7098 |
1E-18 |
18 |
rs7903146 |
0.04998 |
Hypercholesterolemia (HP:0003124)
|
PMID:39024449 |
GWAS1659918_H |
GCST90479546 |
Takes medication for high cholesterol? |
23,091 African American or Afro-Caribbean cases, 32,414 African American or Afro-Caribbean controls, 11,967 Hispanic or Latin American cases, 17,347 Hispanic or Latin American controls, 1,621 East Asian ancestry cases, 1,926 East Asian ancestry controls, 149,973 European ancestry cases, 165,695 European ancestry controls |
C |
0.7098 |
1E-22 |
22 |
rs7903146 |
0.0547 |
drug use measurement (EFO:0007010) Hypercholesterolemia (HP:0003124)
|
PMID:39024449 |
GWAS1660009_H |
GCST90492734 |
Type 2 diabetes |
50,251 African American cases, 103,909 African American controls, 88,109 East Asian ancestry cases, 339,395 East Asian ancestry controls, 242,283 European ancestry cases, 1,569,734 European ancestry controls, 29,375 Hispanic cases, 59,368 Hispanic controls, 1,602 South African ancestry cases, 976 South African ancestry controls, 16,832 South Asian ancestry cases, 33,767 South Asian ancestry controls |
T |
0.22941 |
3E-1315 |
1314.523 |
rs7903146 |
N/A |
|
PMID:38374256 |
GWAS1184456_H |
GCST010555 |
Type 2 diabetes |
148,726 European ancestry cases, 965,732 European ancestry controls |
C |
0.7079 |
3E-695 |
694.523 |
rs7903146 |
0.28 |
|
PMID:32541925 |
GWAS1185584_H |
GCST010554 |
Type 2 diabetes |
8,616 Hispanic cases, 11,829 Hispanic controls |
T |
0.260835 |
3E-19 |
18.523 |
rs7903146 |
0.227926 |
|
PMID:32541925 |
GWAS688389_H |
GCST002783 |
Body mass index |
up to 104,666 European ancestry male individuals, up to 132,115 European ancestry female individuals, 370 African American male individuals, 517 African American female individuals, 512 Hispanic male individuals, 764 Hispanic female individuals |
C |
0.712 |
4E-11 |
10.398 |
rs7903146 |
0.029 |
body mass index (EFO:0004340)
|
PMID:25673413 |
None Available |
GCST90476361 |
red cell diameter width (RDW, mean, inv-norm transformed) |
380,796 European ancestry individuals |
C |
0.7043 |
5E-20 |
19.302 |
rs7903146 |
0.02664 |
Red cell distribution width (EFO:0009188)
|
PMID:39024449 |
GWAS1661723_H |
GCST90476365 |
red cell diameter width (RDW, minimum, inv-norm transformed) |
380,819 European ancestry individuals |
C |
0.7042 |
6E-32 |
31.222 |
rs7903146 |
0.03383 |
Red cell distribution width (EFO:0009188)
|
PMID:39024449 |
GWAS690463_H |
GCST001212 |
Proinsulin levels |
10,701 European ancestry individuals |
T |
0.30 |
2E-20 |
19.699 |
rs7903146 |
N/A |
insulin measurement (EFO:0004467)
|
PMID:21873549 |
GWAS1662479_H |
GCST90475090 |
Hemoglobin A1c (HbA1c, maximum, inv-norm transformed) |
98,772 African American or Afro-Caribbean individuals |
C |
0.7009 |
5E-115 |
114.302 |
rs7903146 |
0.1205 |
HbA1c measurement (EFO:0004541)
|
PMID:39024449 |
None Available |
GCST90479927 |
Hyperlipidemia (PheCode 272.1) |
82,035 African American or Afro-Caribbean cases, 32,046 African American or Afro-Caribbean controls, 39,936 Hispanic or Latin American cases, 15,904 Hispanic or Latin American controls, 4,481 East Asian ancestry cases, 1,867 East Asian ancestry controls, 335,680 European ancestry cases, 90,923 European ancestry controls |
C |
0.71 |
3E-23 |
22.523 |
rs7903146 |
0.05652 |
|
PMID:39024449 |
GWAS1662912_H |
GCST90475123 |
Aspartate aminotransferase (AST, minimum, inv-norm transformed) |
112,345 African American or Afro-Caribbean individuals |
C |
0.7044 |
6E-12 |
11.222 |
rs7903146 |
0.03331 |
aspartate aminotransferase to alanine aminotransferase ratio (EFO:0010934)
|
PMID:39024449 |
None Available |
GCST90479952 |
Obesity (PheCode 278.1) |
52,351 African American or Afro-Caribbean cases, 58,725 African American or Afro-Caribbean controls, 25,279 Hispanic or Latin American cases, 29,030 Hispanic or Latin American controls, 1,613 East Asian ancestry cases, 4,733 East Asian ancestry controls, 169,600 European ancestry cases, 244,254 European ancestry controls |
C |
0.7104 |
3E-17 |
16.523 |
rs7903146 |
0.04237 |
obesity (EFO:0001073)
|
PMID:39024449 |
GWAS1663240_H |
GCST90479929 |
Disorders of lipid metabolism (PheCode 272) |
82,107 African American or Afro-Caribbean cases, 31,954 African American or Afro-Caribbean controls, 39,984 Hispanic or Latin American cases, 15,849 Hispanic or Latin American controls, 4,488 East Asian ancestry cases, 1,866 East Asian ancestry controls, 335,948 European ancestry cases, 90,622 European ancestry controls |
C |
0.71 |
4E-23 |
22.398 |
rs7903146 |
0.0562 |
metabolic disease (EFO:0000589)
|
PMID:39024449 |
None Available |
GCST90479931 |
Gout (PheCode 274.1) |
14,437 African American or Afro-Caribbean cases, 103,731 African American or Afro-Caribbean controls, 3,643 Hispanic or Latin American cases, 55,120 Hispanic or Latin American controls, 1,243 East Asian ancestry cases, 5,416 East Asian ancestry controls, 42,034 European ancestry cases, 397,989 European ancestry controls |
C |
0.7103 |
6E-13 |
12.222 |
rs7903146 |
0.0556 |
gout (EFO:0004274)
|
PMID:39024449 |
GWAS1663406_H |
GCST90475121 |
Aspartate aminotransferase (AST, mean, inv-norm transformed) |
389,192 European ancestry individuals |
C |
0.7034 |
1E-25 |
25 |
rs7903146 |
0.02994 |
aspartate aminotransferase to alanine aminotransferase ratio (EFO:0010934)
|
PMID:39024449 |
None Available |
GCST90475089 |
Hemoglobin A1c (HbA1c, maximum, inv-norm transformed) |
49,229 Hispanic or Latin American individuals |
C |
0.7374 |
2E-43 |
42.699 |
rs7903146 |
0.1028 |
HbA1c measurement (EFO:0004541)
|
PMID:39024449 |
GWAS1187862_H |
GCST002783 |
Body mass index |
up to 104,666 European ancestry male individuals, up to 132,115 European ancestry female individuals, 370 African American male individuals, 517 African American female individuals, 512 Hispanic male individuals, 764 Hispanic female individuals |
C |
0.713 |
1E-12 |
12 |
rs7903146 |
0.024 |
body mass index (EFO:0004340)
|
PMID:25673413 |
GWAS1663750_H |
GCST90476465 |
Weight (minimum, inv-normal transformed) |
119,286 African American or Afro-Caribbean individuals |
C |
0.7048 |
1E-15 |
15 |
rs7903146 |
0.03939 |
body weight (EFO:0004338)
|
PMID:39024449 |
GWAS1663774_H |
GCST90475095 |
Hemoglobin A1c (HbA1c, minimum, inv-norm transformed) |
49,152 Hispanic or Latin American individuals |
C |
0.7375 |
8E-44 |
43.097 |
rs7903146 |
0.1034 |
HbA1c measurement (EFO:0004541)
|
PMID:39024449 |
None Available |
GCST90476394 |
Sodium (mean, inv-norm transformed) |
118,487 African American or Afro-Caribbean individuals |
C |
0.7045 |
9E-12 |
11.046 |
rs7903146 |
0.03199 |
sodium measurement (EFO:0009282)
|
PMID:39024449 |
None Available |
GCST90476396 |
sodium (minimum, inv-norm transformed) |
118,415 African American or Afro-Caribbean individuals |
C |
0.7045 |
7E-14 |
13.155 |
rs7903146 |
0.03456 |
sodium measurement (EFO:0009282)
|
PMID:39024449 |
None Available |
GCST90476395 |
Sodium (mean, inv-norm transformed) |
421,240 European ancestry individuals |
C |
0.7041 |
3E-60 |
59.523 |
rs7903146 |
0.04515 |
sodium measurement (EFO:0009282)
|
PMID:39024449 |
GWAS1664379_H |
GCST90475096 |
Hemoglobin A1c (HbA1c, minimum, inv-norm transformed) |
98,578 African American or Afro-Caribbean individuals |
C |
0.701 |
7E-92 |
91.155 |
rs7903146 |
0.1077 |
HbA1c measurement (EFO:0004541)
|
PMID:39024449 |
None Available |
GCST90476373 |
Biological Sibling: Diabetes / "Sugar" |
40,354 European ancestry cases, 275,314 European ancestry controls |
C |
0.7054 |
3E-41 |
40.523 |
rs7903146 |
0.1065 |
diabetes mellitus (EFO:0000400) family history (EFO:0000493)
|
PMID:39024449 |
GWAS1192244_H |
GCST012043 |
Childhood onset type 2 diabetes |
664 European ancestry youth cases, 1,068 African American youth cases, 1,274 Hispanic youth cases, 1,434 European ancestry adult controls, 1,068 African American adult controls, 3,559 Hispanic adult controls |
T |
NR |
8E-20 |
19.097 |
rs7903146 |
1.58 |
|
PMID:33479058 |
GWAS1665135_H |
GCST90479943 |
Hyperpotassemia (PheCode 276.13) |
5,206 African American or Afro-Caribbean cases, 111,925 African American or Afro-Caribbean controls, 17,226 European ancestry cases, 415,141 European ancestry controls, 2,067 Hispanic or Latin American cases, 55,895 Hispanic or Latin American controls |
C |
0.7082 |
1E-23 |
23 |
rs7903146 |
0.1053 |
Abnormality of metabolism/homeostasis (HP:0001939)
|
PMID:39024449 |
GWAS1665154_H |
GCST90475124 |
Aspartate aminotransferase (AST, minimum, inv-norm transformed) |
389,315 European ancestry individuals |
C |
0.7034 |
5E-32 |
31.302 |
rs7903146 |
0.0336 |
aspartate aminotransferase to alanine aminotransferase ratio (EFO:0010934)
|
PMID:39024449 |
GWAS1665348_H |
GCST90475092 |
Hemoglobin A1c (HbA1c, mean, inv-norm transformed) |
49,225 Hispanic or Latin American individuals |
C |
0.7374 |
9E-48 |
47.046 |
rs7903146 |
0.1084 |
HbA1c measurement (EFO:0004541)
|
PMID:39024449 |
GWAS1665408_H |
GCST90475093 |
Hemoglobin A1c (HbA1c, mean, inv-norm transformed) |
98,735 African American or Afro-Caribbean individuals |
C |
0.701 |
4E-114 |
113.398 |
rs7903146 |
0.121 |
HbA1c measurement (EFO:0004541)
|
PMID:39024449 |
None Available |
GCST90479934 |
Gout and other crystal arthrop (PheCode 274) |
14,867 African American or Afro-Caribbean cases, 102,953 African American or Afro-Caribbean controls, 3,900 Hispanic or Latin American cases, 54,594 Hispanic or Latin American controls, 1,256 East Asian ancestry cases, 5,386 East Asian ancestry controls, 44,197 European ancestry cases, 393,782 European ancestry controls |
C |
0.7103 |
6E-13 |
12.222 |
rs7903146 |
0.05553 |
gout (EFO:0004274)
|
PMID:39024449 |
GWAS1665479_H |
GCST90479951 |
Morbid obesity (PheCode 278.11) |
14,258 African American or Afro-Caribbean cases, 101,561 African American or Afro-Caribbean controls, 5,871 Hispanic or Latin American cases, 51,265 Hispanic or Latin American controls, 202 East Asian ancestry cases, 6,509 East Asian ancestry controls, 45,933 European ancestry cases, 385,784 European ancestry controls |
C |
0.7103 |
6E-36 |
35.222 |
rs7903146 |
0.09375 |
morbid obesity (EFO:0001074)
|
PMID:39024449 |
GWAS1665750_H |
GCST90479683 |
Biological Grandparent (maternal): Diabetes / "Sugar" |
6,090 African American or Afro-Caribbean cases, 49,415 African American or Afro-Caribbean controls, 3,476 Hispanic or Latin American cases, 25,838 Hispanic or Latin American controls, 244 East Asian ancestry cases, 3,303 East Asian ancestry controls, 27,102 European ancestry cases, 288,566 European ancestry controls |
C |
0.7098 |
3E-21 |
20.523 |
rs7903146 |
0.08323 |
diabetes mellitus (EFO:0000400) family history (EFO:0000493)
|
PMID:39024449 |
None Available |
GCST90479916 |
Proteinuria (PheCode 269) |
4,895 African American or Afro-Caribbean cases, 113,073 African American or Afro-Caribbean controls, 1,983 Hispanic or Latin American cases, 56,423 Hispanic or Latin American controls, 212 East Asian ancestry cases, 6,481 East Asian ancestry controls, 10,033 European ancestry cases, 432,072 European ancestry controls |
C |
0.7107 |
1E-15 |
15 |
rs7903146 |
0.09917 |
Proteinuria (HP:0000093)
|
PMID:39024449 |
None Available |
GCST90476462 |
Weight (mean, inv-normal transformed) |
119,279 African American or Afro-Caribbean individuals |
C |
0.7048 |
2E-17 |
16.699 |
rs7903146 |
0.04104 |
body weight (EFO:0004338)
|
PMID:39024449 |
GWAS1666085_H |
GCST90479696 |
Biological Mother: Diabetes / "Sugar" |
13,594 African American or Afro-Caribbean cases, 41,911 African American or Afro-Caribbean controls, 7,144 Hispanic or Latin American cases, 22,170 Hispanic or Latin American controls, 717 East Asian ancestry cases, 2,830 East Asian ancestry controls, 46,816 European ancestry cases, 268,852 European ancestry controls |
C |
0.7098 |
3E-62 |
61.523 |
rs7903146 |
0.1158 |
diabetes mellitus (EFO:0000400) family history (EFO:0000493)
|
PMID:39024449 |
None Available |
GCST90479678 |
magnesium (Mg, maximum, inv-norm transformed) |
43,569 African American or Afro-Caribbean individuals, 18,785 Hispanic or Latin American individuals, 1,637 East Asian ancestry individuals, 145,398 European ancestry individuals |
C |
0.7085 |
2E-12 |
11.699 |
rs7903146 |
0.02601 |
magnesium measurement (EFO:0004845)
|
PMID:39024449 |
GWAS1666338_H |
GCST90479679 |
magnesium (Mg, mean, inv-norm transformed) |
43,608 African American or Afro-Caribbean individuals, 18,807 Hispanic or Latin American individuals, 1,637 East Asian ancestry individuals, 145,571 European ancestry individuals |
C |
0.7085 |
9E-18 |
17.046 |
rs7903146 |
0.03375 |
magnesium measurement (EFO:0004845)
|
PMID:39024449 |
GWAS1666528_H |
GCST90479680 |
magnesium (Mg, minimum, inv-norm transformed) |
43,617 African American or Afro-Caribbean individuals, 18,809 Hispanic or Latin American individuals, 1,638 East Asian ancestry individuals, 145,581 European ancestry individuals |
C |
0.7085 |
5E-14 |
13.302 |
rs7903146 |
0.02877 |
magnesium measurement (EFO:0004845)
|
PMID:39024449 |
GWAS1666589_H |
GCST90475152 |
Body mass index (BMI, maximum, inv-normal transformed) |
118,995 African American or Afro-Caribbean individuals |
C |
0.7047 |
7E-19 |
18.155 |
rs7903146 |
0.04326 |
body mass index (EFO:0004340)
|
PMID:39024449 |
None Available |
GCST012075 |
Fasting insulin |
47,806 European ancestry men |
C |
0.713199 |
0.000001 |
6 |
rs7903146 |
0.020616 |
blood insulin amount (OBA:VT0001560)
|
PMID:33402679 |
GWAS1667032_H |
GCST90476459 |
Weight (maximum, inv-normal transformed) |
119,284 African American or Afro-Caribbean individuals |
C |
0.7048 |
4E-18 |
17.398 |
rs7903146 |
0.04173 |
body weight (EFO:0004338)
|
PMID:39024449 |
GWAS1202391_H |
GCST007931 |
Medication use (HMG CoA reductase inhibitors) |
73,475 European ancestry cases, 216,910 European ancestry controls |
T |
0.290995 |
2E-30 |
29.699 |
rs7903146 |
0.07076007 |
HMG CoA reductase inhibitor use measurement (EFO:0009932)
|
PMID:31015401 |
GWAS1203817_H |
GCST007923 |
Medication use (drugs used in diabetes) |
15,272 European ancestry cases, 29,0641 European ancestry controls |
T |
0.291287 |
4E-145 |
144.398 |
rs7903146 |
0.32730255 |
Drugs used in diabetes use measurement (EFO:0009924)
|
PMID:31015401 |
GWAS1204937_H |
GCST008114 |
Type 2 diabetes |
2,633 African ancestry cases, 1,714 African ancestry controls |
T |
0.356 |
5E-13 |
12.302 |
rs7903146 |
1.32 |
|
PMID:31049640 |
None Available |
GCST90480669 |
red blood cell count (RBC, mean, inv-norm transformed) |
114,768 African American or Afro-Caribbean individuals, 55,750 Hispanic or Latin American individuals, 5,943 East Asian ancestry individuals, 405,366 European ancestry individuals |
C |
0.7102 |
1E-23 |
23 |
rs7903146 |
0.02941 |
erythrocyte count (EFO:0004305)
|
PMID:39024449 |
GWAS1208672_H |
GCST008614 |
Glucosuria |
10,857 Icelandic ancestry cases, 135,512 Icelandic ancestry controls (includes non-array genotyped, whole-genome imputed individuals) |
T |
0.29779 |
4E-20 |
19.398 |
rs7903146 |
1.182 |
Glycosuria (HP:0003076)
|
PMID:30476138 |
GWAS1208677_H |
GCST008605 |
Glucosuria (moderate to severe) |
6,109 Icelandic ancestry cases, 135,512 Icelandic ancestry controls (includes non-array genotyped, whole-genome imputed individuals) |
T |
0.29779 |
3E-17 |
16.523 |
rs7903146 |
1.221 |
Glycosuria (HP:0003076)
|
PMID:30476138 |
GWAS1208856_H |
GCST008606 |
Glucosuria (mild) |
4,748 Icelandic ancestry cases, 135,512 Icelandic ancestry controls (includes non-array genotyped, whole-genome imputed individuals) |
T |
0.2978 |
5E-7 |
6.302 |
rs7903146 |
1.13 |
Glycosuria (HP:0003076)
|
PMID:30476138 |
None Available |
GCST008025 |
Body mass index |
17,127 African American individuals, 21,955 Hispanic/Latino individuals, 4,647 Asian ancestry individuals, 3,936 Native Hawaiian ancestry individuals, 645 Native American ancestry individuals, 1,025 individuals |
? |
NR |
0.000001 |
6 |
rs7903146 |
0.03582819 |
body mass index (EFO:0004340)
|
PMID:31217584 |
None Available |
GCST90480670 |
red blood cell count (RBC, minimum, inv-norm transformed) |
114,768 African American or Afro-Caribbean individuals, 55,750 Hispanic or Latin American individuals, 5,943 East Asian ancestry individuals, 405,369 European ancestry individuals |
C |
0.7102 |
1E-18 |
18 |
rs7903146 |
0.02398 |
erythrocyte count (EFO:0004305)
|
PMID:39024449 |
GWAS1670122_H |
GCST90480673 |
red cell diameter width (RDW, minimum, inv-norm transformed) |
110,610 African American or Afro-Caribbean individuals, 51,949 Hispanic or Latin American individuals, 5,548 East Asian ancestry individuals, 380,819 European ancestry individuals |
C |
0.7103 |
1E-24 |
24 |
rs7903146 |
0.03152 |
Red cell distribution width (EFO:0009188)
|
PMID:39024449 |
GWAS1670286_H |
GCST90480684 |
Biological Sibling: Diabetes / "Sugar" |
10,599 African American or Afro-Caribbean cases, 44,906 African American or Afro-Caribbean controls, 5,431 Hispanic or Latin American cases, 23,883 Hispanic or Latin American controls, 565 East Asian ancestry cases, 2,982 East Asian ancestry controls, 40,354 European ancestry cases, 275,314 European ancestry controls |
C |
0.7098 |
9E-46 |
45.046 |
rs7903146 |
0.1052 |
diabetes mellitus (EFO:0000400) family history (EFO:0000493)
|
PMID:39024449 |
GWAS1670651_H |
GCST90480494 |
Osteomyelitis, periostitis, and other infections involving bone (PheCode 710) |
3,034 African American or Afro-Caribbean cases, 117,552 African American or Afro-Caribbean controls, 10,361 European ancestry cases, 436,629 European ancestry controls, 1,268 Hispanic or Latin American cases, 58,115 Hispanic or Latin American controls |
C |
0.7076 |
1E-13 |
13 |
rs7903146 |
0.09898 |
bone disease (EFO:0004260)
|
PMID:39024449 |
None Available |
GCST90480472 |
Diseases of nail, NOS (PheCode 703) |
12,925 African American or Afro-Caribbean cases, 99,922 African American or Afro-Caribbean controls, 4,055 Hispanic or Latin American cases, 52,334 Hispanic or Latin American controls, 263 East Asian ancestry cases, 6,372 East Asian ancestry controls, 41,535 European ancestry cases, 382,219 European ancestry controls |
C |
0.7109 |
2E-14 |
13.699 |
rs7903146 |
0.05552 |
|
PMID:39024449 |
GWAS1670770_H |
GCST90480654 |
potassium (mean, inv-norm transformed) |
118,506 African American or Afro-Caribbean individuals, 57,434 Hispanic or Latin American individuals, 6,313 East Asian ancestry individuals, 421,503 European ancestry individuals |
C |
0.7103 |
1E-45 |
45 |
rs7903146 |
0.03697 |
potassium measurement (EFO:0009283)
|
PMID:39024449 |
None Available |
GCST90480485 |
Chronic ulcer of leg or foot (PheCode 707.2) |
4,469 African American or Afro-Caribbean cases, 114,940 African American or Afro-Caribbean controls, 18,127 European ancestry cases, 423,634 European ancestry controls, 1,791 Hispanic or Latin American cases, 57,168 Hispanic or Latin American controls |
C |
0.7078 |
2E-17 |
16.699 |
rs7903146 |
0.09099 |
ulcer of lower limb (EFO:0007068)
|
PMID:39024449 |
GWAS1670844_H |
GCST90480702 |
sodium (maximum, inv-norm transformed) |
118,412 African American or Afro-Caribbean individuals, 57,401 Hispanic or Latin American individuals, 6,311 East Asian ancestry individuals, 421,132 European ancestry individuals |
C |
0.7103 |
9E-15 |
14.046 |
rs7903146 |
0.01946 |
sodium measurement (EFO:0009282)
|
PMID:39024449 |
GWAS1670851_H |
GCST90480704 |
sodium (minimum, inv-norm transformed) |
118,415 African American or Afro-Caribbean individuals, 57,381 Hispanic or Latin American individuals, 6,302 East Asian ancestry individuals, 421,073 European ancestry individuals |
C |
0.7103 |
8E-54 |
53.097 |
rs7903146 |
0.03915 |
sodium measurement (EFO:0009282)
|
PMID:39024449 |
None Available |
GCST90475491 |
Biological Mother: Diabetes / "Sugar" |
13,594 African American or Afro-Caribbean cases, 41,911 African American or Afro-Caribbean controls |
C |
0.7053 |
1E-11 |
11 |
rs7903146 |
0.1042 |
diabetes mellitus (EFO:0000400) family history (EFO:0000493)
|
PMID:39024449 |
GWAS1670959_H |
GCST90480486 |
Chronic ulcer of skin (PheCode 707) |
6,201 African American or Afro-Caribbean cases, 111,625 African American or Afro-Caribbean controls, 25,837 European ancestry cases, 409,002 European ancestry controls, 2,479 Hispanic or Latin American cases, 55,884 Hispanic or Latin American controls |
C |
0.7076 |
3E-15 |
14.523 |
rs7903146 |
0.07228 |
chronic ulcer of skin (EFO:0007066)
|
PMID:39024449 |
GWAS1671048_H |
GCST90480703 |
Sodium (mean, inv-norm transformed) |
118,487 African American or Afro-Caribbean individuals, 57,407 Hispanic or Latin American individuals, 6,310 East Asian ancestry individuals, 421,240 European ancestry individuals |
C |
0.7103 |
3E-52 |
51.523 |
rs7903146 |
0.04068 |
sodium measurement (EFO:0009282)
|
PMID:39024449 |
None Available |
GCST90480655 |
potassium (minimum, inv-norm transformed) |
118,507 African American or Afro-Caribbean individuals, 57,434 Hispanic or Latin American individuals, 6,313 East Asian ancestry individuals, 421,506 European ancestry individuals |
C |
0.7103 |
4E-11 |
10.398 |
rs7903146 |
0.01661 |
potassium measurement (EFO:0009283)
|
PMID:39024449 |
GWAS1671215_H |
GCST90480653 |
potassium (maximum, inv-norm transformed) |
118,330 African American or Afro-Caribbean individuals, 57,381 Hispanic or Latin American individuals, 6,307 East Asian ancestry individuals, 421,297 European ancestry individuals |
C |
0.7103 |
2E-50 |
49.699 |
rs7903146 |
0.0374 |
potassium measurement (EFO:0009283)
|
PMID:39024449 |
GWAS1671553_H |
GCST90480493 |
Osteomyelitis (PheCode 710.1) |
2,971 African American or Afro-Caribbean cases, 117,803 African American or Afro-Caribbean controls, 10,097 European ancestry cases, 437,447 European ancestry controls, 1,238 Hispanic or Latin American cases, 58,209 Hispanic or Latin American controls |
C |
0.7076 |
9E-14 |
13.046 |
rs7903146 |
0.1004 |
osteomyelitis (EFO:0003102)
|
PMID:39024449 |
GWAS1671951_H |
GCST90480672 |
red cell diameter width (RDW, mean, inv-norm transformed) |
110,558 African American or Afro-Caribbean individuals, 51,938 Hispanic or Latin American individuals, 5,549 East Asian ancestry individuals, 380,796 European ancestry individuals |
C |
0.7104 |
6E-17 |
16.222 |
rs7903146 |
0.02516 |
Red cell distribution width (EFO:0009188)
|
PMID:39024449 |
None Available |
GCST008474 |
Peripheral artery disease |
24,009 European ancestry cases, 150,983 European ancestry controls, 5,373 African ancestry cases, 42,485 African ancestry controls, 1,925 Hispanic cases, 18,285 Hispanic controls |
T |
0.2937 |
4E-11 |
10.398 |
rs7903146 |
1.06 |
peripheral arterial disease (EFO:0004265)
|
PMID:31285632 |
GWAS1672259_H |
GCST90480379 |
Chronic renal failure [CKD] (PheCode 585.3) |
21,844 African American or Afro-Caribbean cases, 94,448 African American or Afro-Caribbean controls, 6,385 Hispanic or Latin American cases, 51,716 Hispanic or Latin American controls, 708 East Asian ancestry cases, 5,957 East Asian ancestry controls, 63,705 European ancestry cases, 368,937 European ancestry controls |
C |
0.7106 |
8E-29 |
28.097 |
rs7903146 |
0.07055 |
kidney failure (EFO:1002048)
|
PMID:39024449 |
None Available |
GCST90480376 |
End stage renal disease (PheCode 585.32) |
4,335 African American or Afro-Caribbean cases, 116,698 African American or Afro-Caribbean controls, 6,017 European ancestry cases, 443,098 European ancestry controls, 1,295 Hispanic or Latin American cases, 58,338 Hispanic or Latin American controls |
C |
0.7076 |
3E-18 |
17.523 |
rs7903146 |
0.1283 |
chronic kidney disease (EFO:0003884)
|
PMID:39024449 |
None Available |
GCST90480387 |
Disorders resulting from impaired renal function (PheCode 588) |
4,035 African American or Afro-Caribbean cases, 116,190 African American or Afro-Caribbean controls, 7,038 European ancestry cases, 440,105 European ancestry controls, 1,092 Hispanic or Latin American cases, 58,353 Hispanic or Latin American controls |
C |
0.7078 |
3E-11 |
10.523 |
rs7903146 |
0.09583 |
|
PMID:39024449 |
None Available |
GCST90480380 |
Renal failure (PheCode 585) |
31,017 African American or Afro-Caribbean cases, 82,005 African American or Afro-Caribbean controls, 9,310 Hispanic or Latin American cases, 47,503 Hispanic or Latin American controls, 879 East Asian ancestry cases, 5,698 East Asian ancestry controls, 88,771 European ancestry cases, 333,750 European ancestry controls |
C |
0.7104 |
2E-22 |
21.699 |
rs7903146 |
0.05552 |
kidney failure (EFO:1002048)
|
PMID:39024449 |
None Available |
GCST90480705 |
systolic blood pressure (SBP, maximum, inv-normal transformed) |
119,334 African American or Afro-Caribbean individuals, 57,991 Hispanic or Latin American individuals, 6,422 East Asian ancestry individuals, 425,750 European ancestry individuals |
C |
0.7103 |
4E-11 |
10.398 |
rs7903146 |
0.0179 |
systolic blood pressure (EFO:0006335)
|
PMID:39024449 |
GWAS1672879_H |
GCST90480369 |
Nephritis and nephropathy in diseases classified elsewhere (PheCode 580.31) |
1,047 African American or Afro-Caribbean cases, 119,861 African American or Afro-Caribbean controls, 2,540 European ancestry cases, 446,064 European ancestry controls, 520 Hispanic or Latin American cases, 58,901 Hispanic or Latin American controls |
C |
0.7079 |
4E-17 |
16.398 |
rs7903146 |
0.2048 |
nephritis (EFO:1002050)
|
PMID:39024449 |
GWAS1672943_H |
GCST90480377 |
Chronic Kidney Disease, Stage III (PheCode 585.33) |
13,744 African American or Afro-Caribbean cases, 104,364 African American or Afro-Caribbean controls, 4,218 Hispanic or Latin American cases, 54,391 Hispanic or Latin American controls, 436 East Asian ancestry cases, 6,277 East Asian ancestry controls, 43,088 European ancestry cases, 394,787 European ancestry controls |
C |
0.7107 |
2E-25 |
24.699 |
rs7903146 |
0.07554 |
chronic kidney disease (EFO:0003884)
|
PMID:39024449 |
None Available |
GCST90480371 |
Nephritis and nephropathy without mention of glomerulonephritis (PheCode 580.3) |
1,703 African American or Afro-Caribbean cases, 118,429 African American or Afro-Caribbean controls, 4,253 European ancestry cases, 442,584 European ancestry controls, 757 Hispanic or Latin American cases, 58,440 Hispanic or Latin American controls |
C |
0.7079 |
3E-15 |
14.523 |
rs7903146 |
0.1516 |
Nephropathy (HP:0000112) nephritis (EFO:1002050)
|
PMID:39024449 |
None Available |
GCST90480372 |
Nephritis; nephrosis; renal sclerosis (PheCode 580) |
2,669 African American or Afro-Caribbean cases, 116,910 African American or Afro-Caribbean controls, 6,106 European ancestry cases, 438,800 European ancestry controls, 1,048 Hispanic or Latin American cases, 57,967 Hispanic or Latin American controls |
C |
0.7079 |
2E-11 |
10.699 |
rs7903146 |
0.1076 |
kidney disease (EFO:0003086)
|
PMID:39024449 |
None Available |
GCST90480378 |
Chronic Kidney Disease, Stage IV (PheCode 585.34) |
4,501 African American or Afro-Caribbean cases, 116,141 African American or Afro-Caribbean controls, 10,222 European ancestry cases, 437,521 European ancestry controls, 1,506 Hispanic or Latin American cases, 58,041 Hispanic or Latin American controls |
C |
0.7077 |
3E-13 |
12.523 |
rs7903146 |
0.09309 |
chronic kidney disease (EFO:0003884)
|
PMID:39024449 |
None Available |
GCST90480375 |
Renal dialysis (PheCode 585.31) |
3,002 African American or Afro-Caribbean cases, 118,476 African American or Afro-Caribbean controls, 3,469 European ancestry cases, 446,868 European ancestry controls, 908 Hispanic or Latin American cases, 58,878 Hispanic or Latin American controls |
C |
0.7076 |
1E-13 |
13 |
rs7903146 |
0.136 |
renal dialysis (EFO:0010690)
|
PMID:39024449 |
None Available |
GCST90480544 |
Osteoarthritis, localized (PheCode 740.1) |
33,018 African American or Afro-Caribbean cases, 74,880 African American or Afro-Caribbean controls, 13,158 Hispanic or Latin American cases, 40,704 Hispanic or Latin American controls, 984 East Asian ancestry cases, 5,260 East Asian ancestry controls, 108,659 European ancestry cases, 293,849 European ancestry controls |
C |
0.7107 |
2E-12 |
11.699 |
rs7903146 |
0.03621 |
|
PMID:39024449 |
None Available |
GCST90480668 |
red blood cell count (RBC, maximum, inv-norm transformed) |
114,767 African American or Afro-Caribbean individuals, 55,750 Hispanic or Latin American individuals, 5,943 East Asian ancestry individuals, 405,357 European ancestry individuals |
C |
0.7102 |
3E-19 |
18.523 |
rs7903146 |
0.02733 |
erythrocyte count (EFO:0004305)
|
PMID:39024449 |
GWAS1674360_H |
GCST90480078 |
Disorders of refraction and accommodation; blindness and low vision (PheCode 367) |
81,119 African American or Afro-Caribbean cases, 26,217 African American or Afro-Caribbean controls, 34,537 Hispanic or Latin American cases, 17,598 Hispanic or Latin American controls, 3,830 East Asian ancestry cases, 2,180 East Asian ancestry controls, 267,840 European ancestry cases, 131,516 European ancestry controls |
C |
0.7102 |
6E-15 |
14.222 |
rs7903146 |
0.03911 |
Visual impairment (HP:0000505)
|
PMID:39024449 |
GWAS1674582_H |
GCST90480074 |
Myopia (PheCode 367.1) |
20,300 African American or Afro-Caribbean cases, 84,944 African American or Afro-Caribbean controls, 9,317 Hispanic or Latin American cases, 42,799 Hispanic or Latin American controls, 1,535 East Asian ancestry cases, 4,339 East Asian ancestry controls, 65,574 European ancestry cases, 333,242 European ancestry controls |
C |
0.7107 |
3E-14 |
13.523 |
rs7903146 |
0.0462 |
Myopia (HP:0000545)
|
PMID:39024449 |
None Available |
GCST90480075 |
Presbyopia (PheCode 367.4) |
62,465 African American or Afro-Caribbean cases, 40,900 African American or Afro-Caribbean controls, 24,801 Hispanic or Latin American cases, 26,786 Hispanic or Latin American controls, 2,868 East Asian ancestry cases, 3,197 East Asian ancestry controls, 211,535 European ancestry cases, 178,718 European ancestry controls |
C |
0.7107 |
7E-14 |
13.155 |
rs7903146 |
0.03574 |
|
PMID:39024449 |
None Available |
GCST90480069 |
Glaucoma |
38,064 African American or Afro-Caribbean cases, 76,856 African American or Afro-Caribbean controls, 11,570 Hispanic or Latin American cases, 45,339 Hispanic or Latin American controls, 1,446 East Asian ancestry cases, 5,057 East Asian ancestry controls, 81,303 European ancestry cases, 349,418 European ancestry controls |
C |
0.7107 |
3E-11 |
10.523 |
rs7903146 |
0.03792 |
|
PMID:39024449 |
None Available |
GCST90480587 |
Gangrene (PheCode 791) |
1,037 African American or Afro-Caribbean cases, 120,300 African American or Afro-Caribbean controls, 2,052 European ancestry cases, 447,596 European ancestry controls, 403 Hispanic or Latin American cases, 59,313 Hispanic or Latin American controls |
C |
0.7077 |
1E-12 |
12 |
rs7903146 |
0.1874 |
gangrene (EFO:0008574)
|
PMID:39024449 |
GWAS1675046_H |
GCST90480726 |
Weight (maximum, inv-normal transformed) |
119,284 African American or Afro-Caribbean individuals, 57,954 Hispanic or Latin American individuals, 6,419 East Asian ancestry individuals, 425,541 European ancestry individuals |
C |
0.7103 |
8E-53 |
52.097 |
rs7903146 |
0.05312 |
body weight (EFO:0004338)
|
PMID:39024449 |
None Available |
GCST90480127 |
Hypertensive heart and/or renal disease (PheCode 401.2) |
22,462 African American or Afro-Caribbean cases, 90,187 African American or Afro-Caribbean controls, 6,299 Hispanic or Latin American cases, 50,504 Hispanic or Latin American controls, 622 East Asian ancestry cases, 5,912 East Asian ancestry controls, 60,962 European ancestry cases, 358,617 European ancestry controls |
C |
0.7108 |
6E-12 |
11.222 |
rs7903146 |
0.04345 |
kidney disease (EFO:0003086)
|
PMID:39024449 |
None Available |
GCST90480126 |
Hypertensive chronic kidney disease (PheCode 401.22) |
14,127 African American or Afro-Caribbean cases, 101,748 African American or Afro-Caribbean controls, 3,724 Hispanic or Latin American cases, 54,427 Hispanic or Latin American controls, 360 East Asian ancestry cases, 6,302 East Asian ancestry controls, 34,069 European ancestry cases, 399,129 European ancestry controls |
C |
0.7107 |
1E-18 |
18 |
rs7903146 |
0.06852 |
chronic kidney disease (EFO:0003884)
|
PMID:39024449 |
GWAS1231832_H |
GCST90239750 |
Gestational diabetes mellitus |
91 African American cases, up to 985 African American controls, 867 East Asian ancestry cases, up to 2,984 East Asian ancestry controls, 3,780 European ancestry cases, up to 344,902 European ancestry controls, 174 Hispanic American cases, up to 619 Hispanic American controls, 573 South Asian ancestry cases, up to 3,761 South Asian ancestry controls |
T |
NR |
4E-16 |
15.398 |
rs7903146 |
1.22 |
gestational diabetes (EFO:0004593)
|
PMID:35220425 |
None Available |
GCST90480198 |
Atherosclerosis of the extremities (PheCode 440.2) |
4,282 African American or Afro-Caribbean cases, 113,972 African American or Afro-Caribbean controls, 15,036 European ancestry cases, 423,003 European ancestry controls, 1,163 Hispanic or Latin American cases, 57,547 Hispanic or Latin American controls |
C |
0.7079 |
3E-11 |
10.523 |
rs7903146 |
0.07749 |
atherosclerosis (EFO:0003914)
|
PMID:39024449 |
None Available |
GCST90480196 |
Atherosclerosis of native arteries of the extremities with ulceration or gangrene (PheCode 440.21) |
1,050 African American or Afro-Caribbean cases, 120,229 African American or Afro-Caribbean controls, 2,865 European ancestry cases, 446,086 European ancestry controls, 353 Hispanic or Latin American cases, 59,338 Hispanic or Latin American controls |
C |
0.7077 |
2E-13 |
12.699 |
rs7903146 |
0.1759 |
atherosclerosis (EFO:0003914)
|
PMID:39024449 |
None Available |
GCST90480210 |
Peripheral vascular disease |
9,993 African American or Afro-Caribbean cases, 105,769 African American or Afro-Caribbean controls, 42,552 European ancestry cases, 383,626 European ancestry controls, 3,611 Hispanic or Latin American cases, 53,583 Hispanic or Latin American controls |
C |
0.7075 |
1E-14 |
14 |
rs7903146 |
0.05823 |
peripheral vascular disease (EFO:0003875)
|
PMID:39024449 |
GWAS1676543_H |
GCST90480727 |
Weight (mean, inv-normal transformed) |
119,279 African American or Afro-Caribbean individuals, 57,954 Hispanic or Latin American individuals, 6,419 East Asian ancestry individuals, 425,535 European ancestry individuals |
C |
0.7103 |
5E-52 |
51.302 |
rs7903146 |
0.05204 |
body weight (EFO:0004338)
|
PMID:39024449 |
None Available |
GCST90480716 |
total cholesterol (minimum, inv-norm transformed) |
112,278 African American or Afro-Caribbean individuals, 54,881 Hispanic or Latin American individuals, 6,014 East Asian ancestry individuals, 397,646 European ancestry individuals |
C |
0.71 |
4E-17 |
16.398 |
rs7903146 |
0.02203 |
total cholesterol measurement (EFO:0004574)
|
PMID:39024449 |
GWAS1676860_H |
GCST90480729 |
What is your weight? (pounds, inv-normal transformed) |
52,481 African American or Afro-Caribbean individuals, 27,471 Hispanic or Latin American individuals, 3,165 East Asian ancestry individuals, 288,216 European ancestry individuals |
C |
0.7095 |
3E-30 |
29.523 |
rs7903146 |
0.04372 |
body weight (EFO:0004338)
|
PMID:39024449 |
GWAS1240690_H |
GCST001326 |
Type 2 diabetes |
2,413 European ancestry cases, 2,392 European ancestry controls, 810 African American cases, 873 African American controls |
T |
0.26 (EA+AA) |
2E-15 |
14.699 |
rs7903146 |
1.46 |
|
PMID:22101970 |
GWAS774439_H |
GCST000167 |
Type 2 diabetes |
4,549 European ancestry cases, 5,579 European ancestry controls |
T |
NR |
3E-23 |
22.523 |
rs7903146 |
1.37 |
|
PMID:18372903 |
GWAS774560_H |
GCST001809 |
Type 2 diabetes |
842 Punjabi Sikh ancestry cases, 774 Punjabi Sikh ancestry controls |
T |
0.31 |
3E-19 |
18.523 |
rs7903146 |
1.44 |
|
PMID:23300278 |
GWAS774858_H |
GCST001809 |
Type 2 diabetes |
842 Punjabi Sikh ancestry cases, 774 Punjabi Sikh ancestry controls |
T |
0.31 |
6E-22 |
21.222 |
rs7903146 |
1.3 |
|
PMID:23300278 |
GWAS774860_H |
GCST001809 |
Type 2 diabetes |
842 Punjabi Sikh ancestry cases, 774 Punjabi Sikh ancestry controls |
T |
0.3 |
3E-35 |
34.523 |
rs7903146 |
1.15 |
|
PMID:23300278 |
GWAS774863_H |
GCST001809 |
Type 2 diabetes |
842 Punjabi Sikh ancestry cases, 774 Punjabi Sikh ancestry controls |
T |
0.3 |
2E-38 |
37.699 |
rs7903146 |
1.15 |
|
PMID:23300278 |
GWAS774865_H |
GCST001809 |
Type 2 diabetes |
842 Punjabi Sikh ancestry cases, 774 Punjabi Sikh ancestry controls |
T |
0.5 |
9E-75 |
74.046 |
rs7903146 |
1.19 |
|
PMID:23300278 |
GWAS776402_H |
GCST000028 |
Type 2 diabetes |
1,464 European ancestry cases, 1,467 European ancestry controls |
T |
0.26 |
1E-48 |
48 |
rs7903146 |
1.37 |
|
PMID:17463246 |
GWAS776950_H |
GCST001759 |
Type 2 diabetes |
1,101 Indo-European ancestry cases, 1,027 Indo-European ancestry controls |
T |
0.30 |
1E-35 |
35 |
rs7903146 |
1.51 |
|
PMID:23209189 |
GWAS1678195_H |
GCST90480728 |
Weight (minimum, inv-normal transformed) |
119,286 African American or Afro-Caribbean individuals, 57,954 Hispanic or Latin American individuals, 6,419 East Asian ancestry individuals, 425,537 European ancestry individuals |
C |
0.7103 |
2E-45 |
44.699 |
rs7903146 |
0.04653 |
body weight (EFO:0004338)
|
PMID:39024449 |
GWAS777544_H |
GCST000383 |
Type 2 diabetes |
519 Japanese ancestry cases, 503 Japanese ancestry controls |
T |
0.04 |
8E-12 |
11.097 |
rs7903146 |
1.54 |
|
PMID:19401414 |
GWAS777560_H |
GCST000478 |
Type 2 diabetes |
679 European ancestry cases, 697 European ancestry controls |
T |
0.27 |
1E-30 |
30 |
rs7903146 |
1.48 |
|
PMID:19734900 |
GWAS777623_H |
GCST000753 |
Metabolic syndrome |
2,554 Indian Asian ancestry individuals |
A |
0.30 |
7E-7 |
6.155 |
rs7903146 |
1.33 |
metabolic syndrome (EFO:0000195)
|
PMID:20694148 |
None Available |
GCST90480209 |
Peripheral vascular disease, unspecified (PheCode 443.9) |
9,303 African American or Afro-Caribbean cases, 106,823 African American or Afro-Caribbean controls, 39,519 European ancestry cases, 388,133 European ancestry controls, 3,360 Hispanic or Latin American cases, 53,947 Hispanic or Latin American controls |
C |
0.7076 |
1E-14 |
14 |
rs7903146 |
0.06061 |
peripheral vascular disease (EFO:0003875)
|
PMID:39024449 |
GWAS778174_H |
GCST000024 |
Type 2 diabetes |
1,161 European ancestry cases, 1,174 European ancestry controls |
T |
0.18 |
1E-8 |
8 |
rs7903146 |
1.34 |
|
PMID:17463248 |
GWAS1074499_H |
GCST000049 |
Type 2 diabetes |
201 Finland founder cases, 200 Finland founder controls, 200 Ashkenazi Jewish cases, 197 Ashkenazi Jewish controls, 99 European ancestry cases, 100 European ancestry controls |
A |
NR |
5E-8 |
7.302 |
rs7903146 |
1.71 |
|
PMID:17668382 |
None Available |
GCST011340 |
Body fat percentage and fasting glucose (pairwise) |
148,718 European ancestry individuals, 10,072 East Asian, South Asian and African American ancestry individuals |
C |
0.6829 |
7E-10 |
9.155 |
rs7903146 |
N/A |
obsolete_fasting blood glucose measurement (EFO:0004465) body fat percentage (EFO:0007800)
|
PMID:33619380 |
GWAS788596_H |
GCST002352 |
Type 2 diabetes |
12,171 European ancestry cases, 56,862 European ancestry controls, 6,952 East Asian ancestry cases, 11,865 East Asian ancestry controls, 5,561 South Asian ancestry cases, 14,458 South Asian ancestry controls, 1,804 Mexican ancestry cases, 779 Mexican ancestry controls |
T |
0.3 |
8E-75 |
74.097 |
rs7903146 |
1.4 |
|
PMID:24509480 |
GWAS1742336_H |
GCST011332 |
Body mass index and fasting glucose (pairwise) |
380,336 European ancestry individuals, 16,962 East Asian, South Asian, Hispanic and African American ancestry individuals |
C |
0.6829 |
4E-19 |
18.398 |
rs7903146 |
N/A |
obsolete_fasting blood glucose measurement (EFO:0004465) body mass index (EFO:0004340)
|
PMID:33619380 |
GWAS793828_H |
GCST002560 |
Type 2 diabetes |
8,284 African American cases, 15,543 African American controls |
T |
0.3 |
5E-44 |
43.302 |
rs7903146 |
1.33 |
|
PMID:25102180 |
GWAS794046_H |
GCST002560 |
Type 2 diabetes |
8,284 African American cases, 15,543 African American controls |
T |
0.3 |
4E-94 |
93.398 |
rs7903146 |
1.36 |
|
PMID:25102180 |
GWAS794304_H |
GCST002317 |
Type 2 diabetes |
3,848 Mexican and other Latin American ancestry cases, 4,366 Mexican and other Latin American ancestry controls |
T |
NR |
1E-14 |
14 |
rs7903146 |
1.37 |
|
PMID:24390345 |
GWAS794310_H |
GCST000012 |
Type 2 diabetes |
661 European ancestry cases, 614 European ancestry controls |
T |
0.30 |
2E-34 |
33.699 |
rs7903146 |
1.65 |
|
PMID:17293876 |
None Available |
GCST002128 |
Type 2 diabetes |
5,976 Japanese ancestry cases, 20,829 Japanese ancestry controls |
T |
0.04 |
2E-15 |
14.699 |
rs7903146 |
1.48 |
|
PMID:23945395 |
GWAS795341_H |
GCST001550 |
Type 2 diabetes |
2,112 lean type 2 diabetes cases, 4,123 obese type 2 diabetes cases, 54,412 controls |
T |
0.29 |
4E-21 |
20.398 |
rs7903146 |
1.26 |
|
PMID:22693455 |
GWAS795346_H |
GCST001550 |
Type 2 diabetes |
2,112 lean type 2 diabetes cases, 4,123 obese type 2 diabetes cases, 54,412 controls |
T |
0.29 |
2E-40 |
39.699 |
rs7903146 |
1.58 |
|
PMID:22693455 |
GWAS795742_H |
GCST000027 |
Type 2 diabetes |
1,399 European ancestry cases, 5,275 European ancestry controls |
? |
0.30 |
2E-10 |
9.699 |
rs7903146 |
1.38 |
|
PMID:17460697 |
GWAS796222_H |
GCST000277 |
Type 2 diabetes |
958 European ancestry obese cases, 955 European ancestry non-obese cases, 2,938 European ancestry controls |
? |
NR |
6E-16 |
15.222 |
rs7903146 |
1.31 |
|
PMID:19056611 |
GWAS796223_H |
GCST000277 |
Type 2 diabetes |
958 European ancestry obese cases, 955 European ancestry non-obese cases, 2,938 European ancestry controls |
? |
NR |
9E-30 |
29.046 |
rs7903146 |
1.49 |
|
PMID:19056611 |
GWAS1254840_H |
GCST90020027 |
Waist-hip index |
219,872 British ancestry women |
T |
NR |
6E-14 |
13.222 |
rs7903146 |
0.0233495 |
BMI-adjusted waist-hip ratio (EFO:0007788)
|
PMID:34021172 |
None Available |
GCST90061371 |
Peripheral artery disease |
12,086 European ancestry cases, 449,548 European ancestry controls |
T |
0.71 |
5E-10 |
9.302 |
rs7903146 |
1.06 |
peripheral arterial disease (EFO:0004265)
|
PMID:34601942 |
None Available |
GCST90018925 |
Type 1 diabetes |
6,447 European ancestry cases, 451,248 European ancestry controls, 1,219 East Asian ancestry cases, 132,032 East Asian ancestry controls |
T |
NR |
1E-14 |
14 |
rs7903146 |
0.1668 |
|
PMID:34594039 |
None Available |
GCST90018729 |
Weight |
165,419 East Asian ancestry individuals |
T |
0.044689 |
2E-9 |
8.699 |
rs7903146 |
0.0391263 |
body weight (EFO:0004338)
|
PMID:34594039 |
GWAS1682815_H |
GCST90018727 |
Body mass index |
163,835 East Asian ancestry individuals |
T |
0.044621 |
4E-9 |
8.398 |
rs7903146 |
0.0451858 |
body mass index (EFO:0004340)
|
PMID:34594039 |
GWAS1268825_H |
GCST90255621 |
Body mass index |
1,122,049 European ancestry individuals |
C |
NR |
2E-66 |
65.699 |
rs7903146 |
0.0252 |
body mass index (EFO:0004340)
|
PMID:36581621 |
GWAS826943_H |
GCST008833 |
Type 2 diabetes |
2,277 African American cases, 3,098 East Asian ancestry cases, 3,704 European ancestry cases, 6,215 Hispanic/Latino cases, 2,939 South Asian ancestry cases, 2,283 African American controls, 2,921 East Asian ancestry controls, 3,514 European ancestry controls, 5,939 Hispanic/Latino controls, 3,022 South Asian ancestry controls |
T |
0.25 |
1E-41 |
41 |
rs7903146 |
1.34 |
|
PMID:31118516 |
GWAS1278335_H |
GCST90179150 |
Body mass index (MTAG) |
694,649 European ancestry individuals |
T |
NR |
5E-23 |
22.302 |
rs7903146 |
0.01765 |
body mass index (EFO:0004340)
|
PMID:36376304 |
GWAS1302631_H |
GCST006867 |
Type 2 diabetes |
61,714 European ancestry cases, 1,178 Pakistani ancestry cases, 593,952 European ancestry controls, 2,472 Pakistani ancestry controls |
T |
0.291584512494863 |
1E-347 |
347 |
rs7903146 |
0.3059 |
|
PMID:30054458 |
GWAS1304629_H |
GCST008363 |
Offspring birth weight |
210,267 European ancestry individuals, 19,802 individuals |
T |
0.29122800000000004 |
9E-11 |
10.046 |
rs7903146 |
0.021695 |
birth weight (EFO:0004344) parental genotype effect measurement (EFO:0005939)
|
PMID:31043758 |
GWAS1305333_H |
GCST011329 |
Body mass index and type 2 diabetes (pairwise) |
418,152 European ancestry individuals, 31,291 East Asian, South Asian, Hispanic and African American ancestry individuals |
C |
0.6829 |
2E-77 |
76.699 |
rs7903146 |
N/A |
body mass index (EFO:0004340)
|
PMID:33619380 |
None Available |
GCST011331 |
Body mass index and systole blood pressure (pairwise) |
472,402 European ancestry individuals, 16,962 East Asian, South Asian, Hispanic and African American ancestry individuals |
C |
0.6829 |
2E-15 |
14.699 |
rs7903146 |
N/A |
systolic blood pressure (EFO:0006335) body mass index (EFO:0004340)
|
PMID:33619380 |
GWAS1308277_H |
GCST011337 |
Body fat percentage and type 2 diabetes (pairwise) |
200,863 European ancestry individuals, 24,401 East Asian, South Asian and African American ancestry individuals |
C |
0.6829 |
7E-77 |
76.155 |
rs7903146 |
N/A |
body fat percentage (EFO:0007800)
|
PMID:33619380 |
GWAS1314817_H |
GCST90002232 |
Fasting glucose |
200,622 European ancestry individuals |
T |
0.2717 |
2E-35 |
34.699 |
rs7903146 |
0.0259 |
glucose measurement (EFO:0004468)
|
PMID:34059833 |
None Available |
GCST90002238 |
Fasting insulin |
151,013 European ancestry individuals |
T |
0.2717 |
1E-9 |
9 |
rs7903146 |
0.0116 |
insulin measurement (EFO:0004467)
|
PMID:34059833 |
GWAS1317639_H |
GCST90002244 |
Glycated hemoglobin levels |
146,806 European ancestry individuals |
T |
0.2777 |
1E-22 |
22 |
rs7903146 |
0.0133 |
HbA1c measurement (EFO:0004541)
|
PMID:34059833 |
GWAS1324380_H |
GCST006368 |
Body mass index |
315,347 European ancestry individuals, 8,322 Hispanic/Latino individuals, 7,290 East Asian ancestry individuals, 3,069 African American individuals, 459 South Asian ancestry individuals |
C |
NR |
3E-14 |
13.523 |
rs7903146 |
0.021 |
body mass index (EFO:0004340)
|
PMID:30108127 |
GWAS1334802_H |
GCST90093109 |
Type ii diabetes |
16,677 South Asian ancestry cases, 33,856 South Asian ancestry controls |
T |
0.3095 |
3E-54 |
53.523 |
rs7903146 |
0.2436 |
|
PMID:35393509 |
GWAS1334807_H |
GCST90093110 |
Type 2 diabetes (adjusted for BMI) |
16,677 South Asian ancestry cases, 33,856 South Asian ancestry controls |
T |
0.3095 |
8E-59 |
58.097 |
rs7903146 |
0.2641 |
|
PMID:35393509 |
None Available |
GCST90020026 |
Hip index |
219,872 British ancestry women |
T |
NR |
3E-11 |
10.523 |
rs7903146 |
0.02141 |
BMI-adjusted hip circumference (EFO:0008039)
|
PMID:34021172 |
GWAS1339399_H |
GCST90134484 |
Random glucose levels |
5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals |
? |
NR |
7E-18 |
17.155 |
rs7903146 |
N/A |
glucose measurement (EFO:0004468)
|
PMID:35810165 |
GWAS1344769_H |
GCST90002227 |
Two-hour glucose |
63,396 European ancestry individuals |
T |
0.2641 |
3E-26 |
25.523 |
rs7903146 |
0.0854 |
glucose tolerance test (EFO:0004307)
|
PMID:34059833 |
None Available |
GCST90002228 |
Two-hour glucose |
12,578 Hispanic individuals |
T |
0.2413 |
7E-7 |
6.155 |
rs7903146 |
0.1217 |
glucose tolerance test (EFO:0004307)
|
PMID:34059833 |
None Available |
GCST90026416 |
Mild age-related type 2 diabetes |
2,861 Scandinavian ancestry cases, 2,744 Scandinavian ancestry controls |
T |
0.259052 |
6E-16 |
15.222 |
rs7903146 |
1.417 |
|
PMID:34737425 |
GWAS1352660_H |
GCST90026417 |
Type 2 diabetes |
9,486 Scandinavian ancestry cases, 2,744 Scandinavian ancestry controls |
T |
0.285325 |
6E-18 |
17.222 |
rs7903146 |
1.345 |
|
PMID:34737425 |
GWAS1353695_H |
GCST90020025 |
Waist-to-hip ratio adjusted for BMI |
219,872 British ancestry women |
T |
NR |
1E-13 |
13 |
rs7903146 |
0.0230131 |
BMI-adjusted waist-hip ratio (EFO:0007788)
|
PMID:34021172 |
GWAS1353920_H |
GCST90026415 |
Mild obesity-related type 2 diabetes |
1,374 Scandinavian ancestry cases, 2,744 Scandinavian ancestry controls |
C |
0.259052 |
3E-10 |
9.523 |
rs7903146 |
1.402 |
|
PMID:34737425 |
GWAS1354095_H |
GCST90026413 |
Severe insulin-deficient type 2 diabetes |
1,193 Scandinavian ancestry cases, 2,744 Scandinavian ancestry controls |
T |
0.259 |
9E-15 |
14.046 |
rs7903146 |
1.559 |
|
PMID:34737425 |
GWAS1354322_H |
GCST90132287 |
Ideal cardiovascular health score (clinical and behavioral) |
119,129 European ancestry individuals, 16,495 African American individuals, 6,780 Hispanic individuals |
C |
0.29 |
2E-26 |
25.699 |
rs7903146 |
0.07 |
clinical and behavioural ideal cardiovascular health (EFO:0007654)
|
PMID:35613103 |
GWAS1362197_H |
GCST90132186 |
Type 2 diabetes |
40,737 South Asian ancestry individuals |
T |
0.312 |
7E-48 |
47.155 |
rs7903146 |
0.228 |
|
PMID:35551307 |
None Available |
GCST90095034 |
Body mass index |
56,161 Hispanic or Latin American individuals |
T |
0.249 |
2E-10 |
9.699 |
rs7903146 |
0.0486 |
body mass index (EFO:0004340)
|
PMID:35399580 |
GWAS1365126_H |
GCST90132187 |
Type 2 diabetes |
27,417 Hispanic individuals |
T |
0.239 |
4E-34 |
33.398 |
rs7903146 |
0.251 |
|
PMID:35551307 |
GWAS1369268_H |
GCST90132183 |
Type 2 diabetes |
251,740 European ancestry individuals, 139,705 East Asian ancestry individuals, 40,737 South Asian ancestry individuals, 27,417 Hispanic individuals, 30,167 African American individuals, 2,426 Zulu ancestry individuals |
T |
NR |
9E-471 |
470.046 |
rs7903146 |
1.33 |
|
PMID:35551307 |
None Available |
GCST90132934 |
Never eat sugar vs no sugar restrictions (UKB data field 6144) |
447,391 European ancestry individuals |
C |
0.709645 |
3E-11 |
10.523 |
rs7903146 |
0.0148024 |
sugar consumption measurement (EFO:0010158)
|
PMID:32193382 |
GWAS1378022_H |
GCST90301964 |
Glucose levels |
4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals |
T |
0.2656 |
9E-22 |
21.046 |
rs7903146 |
0.0463 |
glucose measurement (EFO:0004468)
|
PMID:38448586 |
None Available |
GCST90475100 |
Albumin (maximum, inv-norm transformed) |
372,948 European ancestry individuals |
C |
0.7034 |
2E-15 |
14.699 |
rs7903146 |
0.02154 |
serum albumin amount (OBA:2050068)
|
PMID:39024449 |
None Available |
GCST90446645 |
Body mass index |
650,000 European ancestry individuals |
C |
0.7276 |
4E-21 |
20.398 |
rs7903146 |
0.0179 |
body mass index (EFO:0004340)
|
PMID:39375568 |
GWAS1391990_H |
GCST90094960 |
Fasting glucose adjusted for BMI |
19,745 European ancestry individuals |
T |
0.2869 |
9E-8 |
7.046 |
rs7903146 |
0.0599 |
BMI-adjusted fasting blood glucose measurement (EFO:0008036)
|
PMID:34951656 |
GWAS1392371_H |
GCST90094959 |
Fasting glucose adjusted for BMI |
52,211 European ancestry, African American or Afro-Caribbean, Hispanic or Latin American, Asian ancestry, Other ancestry, Native American ancestry individuals |
T |
0.2625 |
2E-12 |
11.699 |
rs7903146 |
0.0515 |
BMI-adjusted fasting blood glucose measurement (EFO:0008036)
|
PMID:34951656 |
GWAS1394669_H |
GCST90444202 |
Type 2 diabetes |
51,256 African, African American, East Asian, South Asian, European, Middle Eastern, admixed American, other or other admixed ancestry cases, 370,487 African, African American, East Asian, South Asian, European, Middle Eastern, admixed American, other or other admixed ancestry controls |
C |
0.713835 |
6E-526 |
525.222 |
rs7903146 |
0.4027 |
|
PMID:39379762 |
None Available |
GCST90132315 |
Coronary artery disease |
210,842 European ancestry, East Asian ancestry, unknown cases, 1,167,328 European ancestry, East Asian ancestry, unknown controls |
T |
0.288 |
6E-9 |
8.222 |
rs7903146 |
1.031 |
coronary artery disease (EFO:0001645)
|
PMID:36474045 |
GWAS1406257_H |
GCST90018981 |
Medication use (drugs used in diabetes) |
15,272 European ancestry cases, 290,641 European ancestry controls, 30,515 East Asian ancestry cases, 148,211 East Asian ancestry controls |
T |
NR |
6E-175 |
174.222 |
rs7903146 |
0.3169 |
Drugs used in diabetes use measurement (EFO:0009924)
|
PMID:34594039 |
GWAS1414538_H |
GCST90245849 |
Type 2 diabetes |
12,875 Bangladeshis, Pakistanis ancestry individuals |
T |
0.297 |
2E-17 |
16.699 |
rs7903146 |
1.366 |
|
PMID:35587468 |
GWAS1421160_H |
GCST90132305 |
Coronary artery disease |
190,493 European ancestry cases, 582,775 European ancestry controls, 6,378 Hispanic or Latin American cases, 24,270 Hispanic or Latin American controls, 1,702 African American or Afro-Caribbean cases, 59,507 African American or Afro-Caribbean controls, 29,319 East Asian ancestry cases, 183,134 East Asian ancestry controls |
T |
0.2808 |
6E-10 |
9.222 |
rs7903146 |
0.0263 |
coronary artery disease (EFO:0001645)
|
PMID:35915156 |
GWAS1422877_H |
GCST90271558 |
Random glucose levels |
7,644 African ancestry individuals, 1,503 Chinese ancestry individuals, 7,407 Indian, Pakistani ancestry individuals, 458,862 European ancestry individuals |
T |
0.2869 |
2E-56 |
55.699 |
rs7903146 |
0.005080384 |
glucose measurement (EFO:0004468)
|
PMID:37679419 |
None Available |
GCST90281116 |
Migraine or HOMA-B |
102,084 European ancestry migraine cases, 771,257 European ancestry controls without migraine, 36,466 European ancestry indviduals with HOMA-B |
T |
NR |
2E-9 |
8.699 |
rs7903146 |
0.98 |
HOMA-B (EFO:0004469)
|
PMID:36808568 |
GWAS1434506_H |
GCST90255622 |
Body mass index |
42,752 African ancestry individuals, 55,525 African American individuals |
C |
NR |
2E-8 |
7.699 |
rs7903146 |
0.0288 |
body mass index (EFO:0004340)
|
PMID:36581621 |
None Available |
GCST90271557 |
Random glucose levels |
458,862 European ancestry individuals |
T |
0.29 |
2E-56 |
55.699 |
rs7903146 |
0.0051 |
glucose measurement (EFO:0004468)
|
PMID:37679419 |
None Available |
GCST90432152 |
Abdominal aortic aneurysm |
37,214 European ancestry cases, 997,776 European ancestry controls, 2,007 African ancestry cases, 88,331 African ancestry controls |
? |
NR |
4E-8 |
7.398 |
rs7903146 |
0.0481 |
Abdominal Aortic Aneurysm (EFO:0004214)
|
PMID:37845353 |
GWAS1446239_H |
GCST90428870 |
Gestational diabetes mellitus |
638 Chinese ancestry cases, 1,062 Chinese ancestry controls |
T |
NR |
2E-19 |
18.699 |
rs7903146 |
0.18 |
gestational diabetes (EFO:0004593)
|
PMID:37779084 |
None Available |
GCST90475148 |
Bicarbonate (mean, inv-norm transformed) |
412,513 European ancestry individuals |
C |
0.7042 |
1E-17 |
17 |
rs7903146 |
0.02404 |
blood sodium bicarbonate amount (OBA:2050094)
|
PMID:39024449 |
GWAS1772331_H |
GCST90475150 |
Bicarbonate (minimum, inv-norm transformed) |
412,527 European ancestry individuals |
C |
0.7042 |
5E-19 |
18.302 |
rs7903146 |
0.02418 |
blood sodium bicarbonate amount (OBA:2050094)
|
PMID:39024449 |
GWAS1792774_H |
GCST90479519 |
Bicarbonate (mean, inv-norm transformed) |
112,877 African American or Afro-Caribbean individuals, 54,571 Hispanic or Latin American individuals, 5,460 East Asian ancestry individuals, 412,513 European ancestry individuals |
C |
0.71 |
4E-14 |
13.398 |
rs7903146 |
0.02092 |
blood sodium bicarbonate amount (OBA:2050094)
|
PMID:39024449 |
None Available |
GCST90479520 |
Bicarbonate (minimum, inv-norm transformed) |
112,877 African American or Afro-Caribbean individuals, 54,566 Hispanic or Latin American individuals, 5,459 East Asian ancestry individuals, 412,527 European ancestry individuals |
C |
0.71 |
4E-20 |
19.398 |
rs7903146 |
0.0242 |
blood sodium bicarbonate amount (OBA:2050094)
|
PMID:39024449 |
None Available |
GCST90479600 |
estimated glomerular filtration rate (eGFR, minimum, inv-norm transformed) |
110,854 African American or Afro-Caribbean individuals, 55,243 Hispanic or Latin American individuals, 6,247 East Asian ancestry individuals, 398,886 European ancestry individuals |
C |
0.7103 |
3E-13 |
12.523 |
rs7903146 |
0.0198 |
glomerular filtration rate (OBA:0003747)
|
PMID:39024449 |